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Abstract 
Gliomas are considered to be the most common primary adult malignant brain tumor. 
With the dramatic increases in computational power and improvements in image 
analysis algorithms, computer-aided medical image analysis has been introduced into 
clinical applications. Precision tumor grading and genotyping play an indispensable 
role in clinical diagnosis, treatment and prognosis. Gliomas diagnostic procedures 
include histopathological imaging tests, molecular imaging scans and tumor grading.  
Pathologic review of tumor morphology in histologic sections is the traditional method 
for cancer classification and grading, yet human study has limitations that can result in 
low reproducibility and inter-observer agreement. Compared with histopathological 
images, Magnetic resonance (MR) imaging present the different structure and 
functional features, which might serve as noninvasive surrogates for tumor genotypes. 
Therefore, computer-aided image analysis has been adopted in clinical application, 
which might partially overcome these shortcomings due to its capacity to quantitatively 
and reproducibly measure multilevel features on multi-parametric medical information. 
Imaging features obtained from a single modal image do not fully represent the disease, 
so quantitative imaging features, including morphological, structural, cellular and 
molecular level features, derived from multi-modality medical images should be 
integrated into computer-aided medical image analysis. The image quality 
differentiation between multi-modality images is a challenge in the field of computer-
aided medical image analysis.  
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In this thesis, we aim to integrate the quantitative imaging data obtained from multiple 
modalities into mathematical models of tumor prediction response to achieve additional 
insights into practical predictive value. Our major contributions in this thesis are: 
1. Firstly, to resolve the imaging quality difference and observer-dependent in 
histological image diagnosis, we proposed an automated machine-learning brain tumor-
grading platform to investigate contributions of multi-parameters from multimodal data 
including imaging parameters or features from Whole Slide Images (WSI) and the 
proliferation marker KI-67. For each WSI, we extract both visual parameters such as 
morphology parameters and sub-visual parameters including first-order and second-
order features. A quantitative interpretable machine learning approach (Local 
Interpretable Model-Agnostic Explanations) was followed to measure the contribution 
of features for single case. Most grading systems based on machine learning models are 
considered “black boxes,” whereas with this system the clinically trusted reasoning 
could be revealed. The quantitative analysis and explanation may assist clinicians to 
better understand the disease and accordingly to choose optimal treatments for 
improving clinical outcomes. 
2. Based on the automated brain tumor-grading platform we propose, multimodal 
Magnetic Resonance Images (MRIs) have been introduced in our research. A new 
imaging–tissue correlation based approach called RA-PA-Thomics was proposed to 
predict the IDH genotype. Inspired by the concept of image fusion, we integrate 
multimodal MRIs and the scans of histopathological images for indirect, fast, and cost 
saving IDH genotyping. 
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The proposed model has been verified by multiple evaluation criteria for the integrated 
data set and compared to the results in the prior art. The experimental data set includes 
public data sets and image information from two hospitals. Experimental results 
indicate that the model provided improves the accuracy of glioma grading and 
genotyping.  
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CHAPTER 1. Introduction 
1.1. Motivation 
The widespread use of computer-aided medical image analysis dates back to the 
emergence of digital breast cancer in the early 1990’s [2]. Today, computer-aided 
design (CAD) has become an integral part of medical imaging and diagnostics [3, 4]. 
According to recent research, the possibilities of combining multimodal medical images 
with computer-aided image analysis is very broad [5, 6]. This technology can improve 
the accuracy of disease classification and can reduce the workload of clinicians. 
Histopathological images contain a wealth of structural information, and pathologists 
can not only diagnose tumors but also the extent of cancer cells, the degree of 
malignancy, and the extent of tumor spread [7, 8]. At present, how to build a platform 
for automatically extracting useful information from medical images for diagnosis is an 
area of great interest to many researchers. Compared to magnetic resonance images, the 
extraction of whole slide images (WSIs) is damaging to the human body. Therefore, 
with the development of medical imaging technology, non-invasive magnetic 
resonance images have also begun to be included in the method of tumor diagnosis. For 
clinical medicine, accurate glioma grading is important. It is usually obtained by a 
pathologist manually grading histopathological images. In order to improve the 
accuracy and repeatability, and reduce the empirical differences between different 
observers, computer-aided imaging analysis has been introduced into this area. 
Accurate tumor grading and genotyping are an integral part of clinical cancer research 
and may affect the patient's clinical diagnosis and prognosis [9]. Gliomas diagnostic 
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procedures include imaging tests and tumor grade determination. Although the cause 
of glioma is still unclear, there are still some factors that may increase the risk of glioma, 
including age, radiation exposure, and family genetic history. 
With the continuous development and advancement of medical imaging technology and 
computer technology, medical image analysis has become an indispensable tool and 
technical means in medical research, clinical disease diagnosis, and treatment. In recent 
years, machine learning has rapidly developed into a research hotspot in medical image 
analysis, which can automatically distinguish the characteristics of disease diagnosis 
from the medical image big data. This thesis first briefly describes the characteristics 
of medical image analysis; secondly, the basic principles of machine learning, then 
introduces the main machine learning algorithms mainly used for medical image 
analysis; and finally discusses their research status in the field of medical image 
applications. 
Accurate tumor grading and genotyping play a significant role in oncology [9]. For 
instance, computational-aid tumor histopathological grading may help the junior 
pathologists improve their diagnose accuracy. Tumor grading and genotyping are the 
basis for the treatment of clinical diagnosis. As in clinical diagnose procedure, the 
whole process are depend on the experience of clinicians, which may contain subjective 
and not easy for junior doctors. Compared with traditional methods predicted by 
pathologists, computer-aided grading and genotyping have the advantages of 
repeatability and low labor consumption. 
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1.2. Challenges 
Multi-parametric medical image analysis faces some serious challenges. 
Comprehensive diagnostic information cannot be obtained from a single medical alone. 
In computer-aided medical image analysis, different modal medical information with 
different qualities make it difficult to accurately integrated and fully utilized. 
1.2.1. Multimodal Medical Image Fusion 
The digital processing of medical images has become a practical clinical technique, 
which is widely used in various medical imaging disciplines, such as histopathological 
images, MRI and PET. Different imaging modalities are highly specific and can be 
divided into anatomical images (CT, MRI) and functional images (PET) from a medical 
perspective [10, 11]. Anatomical images can clearly show the anatomy of internal 
organs and bones with high spatial resolution and geometric characteristics, but does 
not have the function information display; while functional images can display the 
transformation of the human body's metabolic function, providing the body function 
information, but the image is blurred. It is impossible to clearly reflect the 
morphological structure, it is difficult to obtain accurate anatomical structure and 
stereoscopic positioning, and it is difficult to distinguish the boundaries of tissues and 
organs. Therefore, comprehensive diagnostic information cannot be obtained from a 
single image alone. For example, through image registration, images of different 
modalities are mapped into the same coordinate system, which reflects the 
corresponding tumor regions are in the same position in space. This can reflect the 
comprehensive information of various forms and functions of the human body, so that 
the lesion or ROI has clear visibility, which has important application value in the 
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positioning of the lesion, design of the radiotherapy plan, guiding the operation and 
checking the therapeutic effect. 
Common multimodal medical image fusion methods found in recent researches 
including intensity-hue-saturation (IHS) and principal component analysis (PCA) 
method [12], fuzzy set method (type-2 fuzzy logical method [13] and fuzzy transform 
method [14]), Neural network method (non-subsampled contour-let transform and 
pulse-coupled neural network [15]), and wavelet transform method [11, 16, 
17].Heterogeneity of medical information 
In conventional clinical image acquisition, differences in various imaging parameters, 
such as pixel size, matrix size, slice thickness, tumor position, and reconstruction 
algorithms, need to be considered. When meaningful data is extracted digitally to 
analyses the image phenotypes, discrepancies in these imaging parameters may lead to 
some changes that are not due to potential biological effects. It is therefore necessary 
to use standardized imaging protocols to eliminate the variability of unnecessary 
confounding factors. 
1.3. Contributions 
In this thesis, we target at integrating the quantitative imaging data obtained from 
multiple modalities into mathematical models of tumor prediction response to achieve 
additional insights into practical predictive value. Our major contribution in this thesis 
are summarized below: 
1. We proposed an automated machine-learning brain tumor-grading platform to 
investigate contributions of multi-parameters from multimodal data including 
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imaging parameters or features from the Whole Slide Images (WSI) and the 
proliferation marker KI-67. For each WSI, we extract both visual parameters 
such as morphology parameters and sub-visual parameters including first-order 
and second-order features. On the basis of machine learning models, our 
platform classifies gliomas into grades II, III, and IV. 
2. A quantitative interpretable machine learning approach (Local Interpretable 
Model-Agnostic Explanations) was proposed to measure the contribution of 
features for single case. Most of the grading systems based on machine learning 
models are considered “black boxes,” and it would be valuable for patient 
management if clinically trusted reasoning could be revealed. The quantitative 
analysis and explanation may assist clinicians to better understand the disease 
and accordingly to choose optimal treatments for improving clinical outcomes. 
3. Based on the automated brain tumor-grading platform we proposed above, 
multimodal MRIs have been introduced in our research. A new imaging –tissue 
correlation based approached called RA-PA-Thomics was proposed to predict 
the IDH genotype. Inspired by the concept of image fusion, we integrate 
multimodal MRIs and the scans of histopathological images for indirect, fast, 
and cost saving IDH genotyping. 
1.4. Thesis Organizations 
This thesis has been organized to follow the normal procedures of the multi-modality 
biomedical imagery. As shown in Figure 1, the overview plan of this thesis has been 
listed. Computer-aided biomedical images analysis is reviewed and discussed in 
Chapter 2. Also, in this chapter, we introduced the machine-learning application in the 
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computer-aided biomedical imaging analysis field. As for Chapters 3 and 4 are present 
the proposed models we figure out. In the end, Chapter 5 summarise our conclusions 
and forecasts the research trend of multi-parametric imaging data processing analysis 
for brain tumour diagnoses. 
 
Figure 1 Outline of Thesis 
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CHAPTER 2. Background 
In this chapter, we have summarized related work on multi-parametric medical image 
analysis. We first briefly introduce the applications of computer-aided medical image 
analysis, followed by the image description (histopathological images and MRIs) 
techniques that we will typically utilize for model validation. Finally, we provide the 
literature review of computer-aided multi-parametric medical image analysis procedure. 
2.1. Applications of Multi-parametric Medical Image 
Analysis 
Computational Analysis for Clinical Diagnose: At present, the most widely 
used machine learning application in biomedical imaging field is the use of computer-
aided biomedical imaging analysis and diagnosis. For example:  
1) Targeting in the field of radiotherapy, the first half of radiotherapy should first 
outline the boundary between the surrounding organs and the tumor. In terms 
of computer-aided medical analysis, machine-learning based segmentation can 
better to figure out the edge of the tumor. 
2) Automated analysis of pathological images, pathological diagnosis is the gold 
standard, but usually, the picture pixels are very high, where AI can effectively 
prevent missed diagnosis and accelerate diagnosis; 
3) Early screening for disease, such as early screening for pulmonary nodules. 
Image retrieval applied in medical applications: Machine-learning 
algorithms in computer-aided biomedical imaging fields have been widely used. 
20 
 
Content Based Image Retrieval (CBIR) is an image retrieval algorithm that is widely 
used in the medical field. CBIR is also known as Query by Image Content (QBIC), 
which provides technology that allows digital images to be organized through their 
visual features.  The implementation of this technology depends on two aspects:  
1) Computer vision technology,  
2) An image library with a large amount of data.  
CBIR is implemented by matching similar images to a fixed image in a massive 
database. CBIR is widely used in medical imaging, including segmentation and 
diagnosis of region of interest. For example, pathologists and researchers can use CBIR 
for tumor grade prediction by retrieving ROI in pathological images and extracting 
relevant features [18-24]. CBIR can be considered as unsupervised learning [23]. Due 
to the insufficient number of labelled data, this unsupervised learning algorithm is more 
suitable for biomedical field [21, 22].  
Discovering the Relationships between Multimodalities Biomedical Images 
and Clinical Information: According to research, pathologists and researchers obtain 
important findings in the current clinical diagnosis of diseases such as invasive tumors 
by observing histopathological images. At the same time, along with the advancement 
of medical information digital and genomic analysis techniques, and the development 
of missiology, multi-modalities of medical imaging (MRI, WSIs, CT), genomic 
information, and clinical information are integrated into the final diagnosis [25]. 
Researchers and clinicians attempted to analyze the relationship between these data and 
discover the relationships between medical images of different modalities and the 
relationships between images in the same modality [26, 27]. However, a single whole 
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slide image may contain millions of nuclei information. It is unrealistic for researchers 
and clinicians to observe, identify and analyze such a large amount of data. At the same 
time, the analysis is considered subjective and non-repeatable. Machine learning has 
the potential to help with analyses that are instead both objective and repeatable. This 
is already being used in several fields, for example, prognostic analysis of current 
common cancer patients [28-31], genotype prediction [31, 32], and tumor grading [33-
35]. 
2.2. Multi-parametric Biomedical ImagesWhole Slide images 
As a gold standard for pathological diagnosis, histopathological images have important 
applications in clinical and scientific research [36-38]. The pathologist performs a 
pathological diagnosis and a prognostic evaluation by microscopic examination of the 
pathological section, but this process is usually time consuming and laborious. The 
advent of digitization of pathological sections is considered an important turning point 
in the pathological development process [39, 40]. The production of digital pathology 
sections first requires tissue staining and subsequent digitization into digital pathology 
sections by a microscopy camera [41]. However, due to the low quality of the original 
digital slice, its popularity was limited. In 1999, the whole digital image appeared, 
making the preservation and transmission of pathological slices more convenient and 
safe [42]. 
Whole slide images (Figure 2) refer to the cutting of a certain size of the diseased tissue, 
using hematoxylin and blush (H & E) and other staining methods to make the sliced 
tissue into a pathological slide, and then microscopic imaging technology to 
microscopic cells and glands. By analyzing the pathological images, the causes, 
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pathogenesis, and pathogenesis of the lesions can be explored to make a pathological 
diagnosis. 
 
Figure 2 Huge size of Histopathological Images 
Histopathological images are usually scanned at high resolution and the images we 
collected may exceed 1GB in size (Figure 3) [43, 44]. This kind of large tissue contains 
a large amount of redundant information.  
 
Figure 3 Multi-resolution of the same whole slide images. The left image was 
scanned at 10X resolution; it is difficult for pathologists to extract enough 
information directly from them. The image on the right is the field of view under 
40x resolution. 
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2.2.2. Magnetic resonance imaging (MRI)  
Human glioma is a common primary malignant tumor of the brain. The current 
treatment is still mainly surgical resection. After surgery, it is supplemented with 
radiotherapy and chemotherapy. However, different pathological grades have different 
malignant degrees and different responses to treatment. Recent studies have shown a 
relationship between MRI features and pathological grades of human gliomas and cell 
proliferation, genotype, and prognosis, which could be used to improve these outcomes. 
Compared with WSIs, MRI of the brain is a safe and non-invasive medical imaging 
method that uses electromagnetic waves to draw detailed images of the brain. MRI [45], 
which is a measure of the magnitude of a magnetic resonance signal generated by a 
hydrogen atomic nucleus in human tissues and organs under the action of an strong 
external magnetic field, and is performed by the computer on the information data 
received by the external nuclear magnetic resonance signal detector. The concentration 
of atoms in the body, most commonly hydrogen, can be used to map the density of 
tissue in the body. Nuclear magnetic resonance can be used to identify where these 
atoms are concentrated, and the results can be mapped into an image of the body by a 
computer.  3D image reconstruction. It provides very clear images of human soft tissue 
anatomy and lesions. 
Multimodal MRI imaging, a method in which multiple functional magnetic resonance 
imaging modes are fused together to diagnose and examine patients, is a rapidly 
evolving technique in brain imaging (Figure 4), including T1, T1 contrast, T2 and Fluid 
attenuation inversion recovery (FLAIR) [46, 47]. It provides information on tissue 
anatomy, functional metabolism, etc. [48] It is characterized by high resolution, high 
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precision, and non-invasiveness, which is helpful for a more accurate depiction of the 
edge of the lesion before surgery. 
 
 
Figure 4 Multimodal MR Images. Brain MR Images using different imaging 
modalities: T1, T1 contrast, T2 and T2/FLAIR. 
2.3. Multi-modality Image Analysis Procedure 
The process of multi-modality image analysis can be divided into five steps as follows 
(Figure 5): image acquisition, the region of interest (ROI) extraction, features 
extraction, feature selection, consequence interpretation and analysis. 
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Figure 5 The procedure of multi-modality biomedical images analysis. The first 
step is to collect multi-modality biomedical images, including the scans of 
histopathological images, multi-modal MR images. Next, applying these images 
into segmentation algorithms. Furthermore, based on the ROIs, we automatically 
and quantitatively extract multi-parametric features. Then, through feature 
selection algorithms, we select optimal features and implement into machine-
learning algorithms to predict the outcomes.  
2.4. Segmentation  
Medical image segmentation is the process of dividing an image into regions based on 
similarities or differences between regions. At present, images of various cells, tissues 
and organs are mainly used as objects of treatment. The traditional image segmentation 
technology has a region-based segmentation method and a boundary-based 
segmentation method. The former relies on the spatial local features of the image, such 
as the uniformity of grayscale, texture and other pixel statistical properties. The latter 
mainly uses gradient information. The latter mainly uses gradient information to 
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determine the boundaries of the target. With the combination of specific theoretical 
tools, image segmentation technology has been further developed. 
In recent years, with the development of other emerging disciplines, some new image 
segmentation techniques have emerged such as statistical methods [49-51], fuzzy 
theory-based methods [52, 53], neural network-based methods [54, 55], wavelet 
analysis-based methods [56], model-based snake models (dynamic contour models [57, 
58]), combined optimization models and other methods. Although new methods of 
segmentation have been proposed, the results are not satisfactory. The current research 
hotspot is a knowledge-based segmentation method, which introduces some 
transcendental knowledge into the segmentation process by some means, thus 
constraining the segmentation process of the computer so that the segmentation result 
is controlled within the range we can recognize. For example, when the intrahepatic 
mass and the normal liver gray value are very different, the mass and the normal liver 
are not regarded as two independent tissues. 
The research of medical image segmentation method has the following remarkable 
features: any single image segmentation algorithm has difficulties obtaining 
satisfactory results for general images – more attention should be paid to the effective 
combination of multiple segmentation algorithms. Although there have been studies to 
distinguish the required organs, tissues or methods to find the lesions by automatic 
segmentation of medical images, currently available software packages generally still 
cannot complete fully automatic segmentation and still require anatomical aspects 
manual intervention [59]. In the current situation that the image segmentation task 
cannot be completely completed by a computer, the human-computer interactive 
segmentation method has gradually become the research focus; the new segmentation 
27 
 
methods have several goals: automatic, precise, fast, adaptive and robust segmentation. 
The comprehensive utilization of classical segmentation technology and modern 
segmentation technology (integration technology) is an appropriate goal for the future 
development of medical image segmentation technology [49, 60]. 
Compared to the 2-dimensional histopathological image, the Volume of Interest (VOI) 
outlined on the MRI is 3-dimensional. The specific steps are as follows: First, two 
experienced radiologists will outline the VOI of the image. When the two opinions are 
inconsistent, they are judged by another senior title physician. Secondly, using the 
MATLAB (R2017b)-based boundary sketching program, based on the enhanced T1WI 
image and other modal sequences as a reference, manually extract the maximum extent 
of the diseased tissue at each level of the visible lesion as the ROI of the layer. Stacking 
multiple levels of ROI together generates a VOI on the patient's enhanced T1WI image. 
Finally, the VOI boundary on the enhanced T1WI image is automatically copied to 
several other parameter maps that have been registered, and finally the multimodal VOI 
of each patient image is obtained. 
Segmentation algorithms are usually divided into three categories; manual, 
semiautomatic, and automatic segmentation. There is no absolutely perfect algorithm 
for image segmentation as each category faces different opportunities and challenges. 
Firstly, manual segmentation relies on physician experience; they evaluate each slice 
of the radiologic imaging sequence or pathological cell subtype information to delineate 
the ROIs. Although it is time-consuming and tiresomeness, it is very effective in 
reproducibility and reliability for tumors with large morphological variations and 
partially blurred volumes.  
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Secondly, in the face of the large number of data that is needed to delineate the ROIs, 
it is often necessary to rely on the assistance of semi-automatic algorithms to reduce 
the number of human interactions as much as possible and improve the segmentation 
efficiency.  
Thirdly, with the development of segmentation algorithms based on artificial networks, 
many fully automated algorithms overcome the challenges of unclear boundaries and 
different shapes. 
For clinical diagnosis, accurate histopathological grading and subtyping are critical, 
which may further influence the surgical treatment and prognosis analysis. From Figure 
4, we can see that a single histopathological image may contain different kinds of 
features. 
2.5. Feature Extraction 
At present, there are many feature extraction methods, and the feature extraction 
methods used according to different purposes and different targets are also different. 
Commonly used image feature types can be divided into： 
1) Grayscale features of the image [61, 62], such as the mean or variance of the 
image or local;  
2) Texture features of the image [58, 63], such as co-occurrence matrix, equal 
grayscale run length, Fourier spectrum, random field model, etc.;  
3) Spectral features of the image [64] Gradient features of image grayscale 
transformation;  
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4) Image object shape features [65, 66] such as area, perimeter, circularity, aspect 
ratio, moment, edge moment, Fourier descriptor, eccentricity, compactness, etc.;  
5) Image information description and Signal to noise ratio and so on. 
2.5.1. Features used in Histopathological Image Analysis 
The WSI pathology image contains massive structural information [67, 68]. Therefore, 
converting images into mineable feature data is a necessary step in the pathological 
analysis [69, 70]. The method of feature extraction can be divided into artificial feature 
design and automatic feature learning. Artificial feature design refers to the selection 
and simplification of low-dimensional vectors that can best express image content from 
images. These features include gray histograms [71], shape features [72, 73], texture 
features, and relationships with surrounding tissues. Digital pathology slice analysis of 
traditional machine learning algorithms requires manual extraction of features. 
However, the application of artificial features has the following disadvantages: First, 
feature selection relies heavily on professional experience, objectivity is poor, and it is 
impossible to represent comprehensive information of pictures; second, there is a lack 
of principle criteria for integrating multiple artificial features. 
As shown in Figure 6, we can figure out that a single histopathological image may 
contain different kind of features. 
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Figure 6 Presentation of different features in the histopathological image. 
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2.5.1.1 Pixel-level Features [68, 72]: Pixel-level image features refer to 
features that are unexplained in biology, which lied in the bottom of the information 
hierarchy. Pixel-level image features usually refer to some small details in the image, 
such as edge, corner, color, pixels, gradients, etc., which can be obtained by filter, 
SIFT or HOG. 
2.5.1.2 Object-level Features [72, 74]: Compared with pixel-level 
characteristics, characterized in object-level information of the higher level hierarchy. 
This layer is characterized mainly described the histopathological characteristics of 
the image in the cell structure, for example, nuclei and glands. Generally, object-level 
features can be divided into the following categories: size and shape, radiometric and 
densitometry, texture, and chromatin-specific [43].  
2.5.1.3 Spatially Related Features [75]: Spatially related features refer 
to the topological features of image structure information. This kind of feature was 
introduced as early as the 1990s, but it has only recently appeared in medical image 
analysis [76]. Such features provide a wealth of structure information to describe 
histopathological images, including cell distribution and image globalist. 
2.5.2. Features used in Magnetic Resonance Imaging Analysis 
In the field of biomedical imaging analysis, radiomics is a method of extracting massive 
features from emission images using different data feature algorithms. Radiomics 
features can be divided into shape-based features, first-order statistics features, texture 
features and features extracted by using different filters [77]. 
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2.5.2.1 Shape-based Features: Measures include the description of the 
volume of tumor areas, such as volume, surface area, maximum diameter in two and 
three dimensions, and effective diameter, and features describing the degree of 
similarity between the ROI and the sphere, such as Surface volume ratio, density, 
eccentricity, sphericity, etc. In short, it is a feature of geometry, which has the same 
meaning as the volume we calculate. For example, sphericity describes the measure 
of the roundness of the tumor area relative to the sphere. The higher value (0 <
𝑆𝑝ℎ𝑒𝑟𝑖𝑐𝑖𝑡𝑦 ≤ 1) implies the higher the roundness of the ROI. The value is calculated 
as: 
𝑆𝑝ℎ𝑒𝑟𝑖𝑐𝑖𝑡𝑦 =
√36𝜋𝑉2
3
A
 (2.1) 
Where V is the volume of ROI and A is the surface of ROI. 
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2.5.2.2 First-order Statistics Features: The first-order statistics 
features, also named intensity features, which measures the intensity distribution 
characteristics in ROIs (it is a feature that can be calculated statistically on the grey 
value of an image), do not include spatial features between pixels. These intensity 
features are obtained by histogram analysis, including the mean, median Number, 
minimum, maximum, standard deviation, skewness, and kurtosis. These features 
reflect the symmetry, uniformity, and local intensity distribution of the measured 
voxels. For example, energy describes the magnitude of voxel values in the ROI [78].  
A larger value implies a greater sum of the squares of these values. The function is 
defined as below: 
𝑒𝑛𝑒𝑟𝑔𝑦 = ∑(𝑋(𝑖) + 𝑐)2
𝑁𝑝
𝑖=1
 (2.2) 
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2.5.2.3 Texture Features: The texture features describe the intensity of 
the voxel spatial distribution, which can also be called as the second-order statistics 
features. Image texture refers to a spatial change that is perceptible or measurable at 
the intensity level. It is treated as a gray level and is a combination of local features 
of visual perception. The second-order features include Gray Level Co-occurrence 
Matrix (GLCM), Gray Level Size Zone Matrix (GLSZM), Gray Level Run Length 
Matrix (GLRLM), Neighboring Gray Tone Difference Matrix (NGTDM) and Gray 
Level Dependence Matrix [78, 79]. These kinds of statistical features reflect the 
inhibition between different parts of the tumor region by quantifying the difference in 
grayscale regions in the image. For example, the GLDM features quantify the grey 
level dependences in an image. The function as below: 
𝐷𝑒𝑝𝑒𝑛𝑑𝑒𝑛𝑐𝑒 𝑁𝑜𝑛 − 𝑈𝑛𝑖𝑓𝑜𝑟𝑚𝑖𝑡𝑦 𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 =  
∑ (∑ 𝑃(𝑖, 𝑗)
𝑁𝑔
𝑖=1 )
2
𝑁𝑑
𝑗=1
𝑁𝑧2
 (2.2) 
Where 𝑁𝑔 be the number of discreet intensity values in the image, 𝑁𝑑 be the number of discreet 
dependency sizes in the image, 𝑁𝑧 be the number of dependency zones in the image, which is 
equal to∑ ∑ 𝑃(𝑖, 𝑗)
𝑁𝑑
𝑗=1
𝑁𝑔
𝑖=1 , and 𝑃(𝑖, 𝑗) be the dependence matrix. 
2.6. Feature Selection 
In the practical application of machine learning, massive features are usually extracted, 
and there may be irrelevant features. There may also be interdependencies between 
features, which may lead to the following consequences: 1) The more features extracted, 
the longer it takes to analyze features and train the model; 2) The more features are 
extracted, the more complex the model will be and the lower the promotion ability. 
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Feature selection can reduce redundant information by removing invalid features, 
thereby improving model prediction capabilities. On the other hand, the model is 
simplified by selecting the optimal features to facilitate understanding and visualization 
of the data. 
Feature selection has two main functions: 1) Reduce feature quantity and dimension 
reduction, make the model generalization ability stronger, and reduce over-fitting; 2) 
Enhance understanding between features and eigenvalues. 
In this section, I will simply introduce several feature selection algorithms: 
Removing Features with Low Variance: This should be the simplest feature 
selection method: suppose the eigenvalues of a feature are only 0 and 1, and in all input 
samples, 95% of the instances have a value of one, then it can be considered that this 
feature does not work. Big. If 100% is one, then this feature is meaningless. This 
method can be used when the eigenvalues are discrete variables. If it is a continuous 
variable, the continuous variables need to be discretized before they can be used. In 
practice, generally, 95% or more will take a certain value. The characteristics exist, so 
this method is simple but not very useful. It can be used as a pre-processing for feature 
selection. First, the features with small changes in value are removed, and then the 
appropriate feature selection is selected from the feature selection methods mentioned 
below for further feature selection. 
Univariate Feature Selection: Univariate feature selection tests each feature 
measures the relationship between the feature and the response variable and discards 
bad features based on the score. For regression and classification problems, features can 
be tested by means of the chi-square test. This method is relatively simple, easy to run, 
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easy to understand, and usually has a good effect on understanding the data (but not 
necessarily effective for feature optimization and generalization); there are many 
improved versions and variants of this method. 
Radom Forest: First, it will shuffle the original features and add them to the 
dataset as new features. Then, the random forest model is trained based on all features 
and the importance of each feature is evaluated. In each iteration, the method detects 
whether the real feature is more important than its shadow feature and removes features 
with the least difference in importance. Finally, the algorithm stops after all features are 
judged to be important or useless (or stops after a given number of iterations). 
Recursive Feature Elimination (RFE): The coef_ attribute returned by the 
learner or the feature_importances_ attribute is used to get the importance of each 
feature. Then, remove the least important feature from the current feature set. This step 
of recursively is repeated over the set of features until the desired number of features is 
finally reached. This algorithm optimizes the model by continuously recursively 
removing features and re-establishing the model on the features. The stability of an RFE 
depends largely on which model is used at the bottom of the iteration. For example, if 
the ordinary regression used by RFE is unstable without regularization, then RFE is 
unstable; if Ridge is used, and the regression with Ridge regularization is stable, then 
RFE is stable. 
37 
 
2.7. Machine-Learning Models Establishment and 
Prediction 
As shown in Figure 7, we can directly see that the normal procedure in biomedical 
imaging analysis field via machine-learning algorithms. As mentioned before, several 
procedures have been adopted include multi-modality biomedical images acquisition, 
the selection of region of interests, features extraction and optimal feature selection 
before establish predictive machine-learning models. 
 
Figure 7 Prediction Model Establishment via machine learning algorithms. After 
the biomedical imaging pretreatment process, the commonly used machine 
learning algorithms in the biomedical imaging analysis field can be divided into 
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the following categories: (a) supervised learning, (b) unsupervised learning, (c) 
semi-supervised learning, and (d) multiple instance learning 
As figured out in recent researches, machine-learning algorithms implemented into 
computer-aided biomedical imaging analysis field can be simply divided into the 
following categories: supervised learning, unsupervised learning, semi-supervised 
learning and multiple instance learning. 
Supervised Learning: Supervised learning is a machine learning method in 
which a training model can be learned or established and a new instance can be inferred 
from this model. Training data consists of input objects (vectors) and expected outputs. 
The output of a function can be a continuous value (regression analysis) or a prediction 
of a classification label (classification). 
The task of a supervised learner, after observing some training paradigms (inputs and 
expected outputs), predicts the output of this function for any possible input values. To 
achieve this goal, learners must generalize from existing sources to non-observed 
situations in a "reasonable" (see induction bias) manner. In human and animal 
perception, it is often referred to as concept learning. 
Supervised learning has two models of morphology. Most generally, supervised 
learning produces a global model that maps input objects to expected output. The other 
is to implement this correspondence in a regional model. (such as case inference and 
nearest neighbor law). 
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The most widely used classifiers are artificial neural networks [80, 81], support vector 
machines [82], nearest neighbor [83], Gaussian mixture models [62], naive Bayesian 
methods [84], decision trees [85], and radial basis function classification [86]. 
Unsupervised Learning: No samples were labelled. In fact, unsupervised 
learning can't carry out targeted classification, fitting, and can only do some analytical 
tasks, such as clustering [87, 88], PCA [89], dictionary learning [90, 91]. 
Unsupervised Learning is an algorithm of artificial intelligence networks. Its purpose 
is to classify the original data in order to understand the internal structure of the data. 
Unlike the supervised learning network, the unsupervised learning network does not 
know whether the classification result is correct when learning, that is, it is not 
supervised (it tells it which learning is correct). It is characterized by providing input 
examples for only one type of network, and it automatically finds its potential category 
rules from these examples. After learning and testing, you can also apply it to new cases. 
A typical example of unsupervised learning is clustering [87]. The purpose of clustering 
is to bring together similar things, and we do not care what this class is. Therefore, a 
clustering algorithm usually only need to know how to calculate the similarity and can 
start working. 
Semi-supervised Learning: One part has a mark, and the other part only has 
data not marked. At this time, it is necessary to combine unmarked data with marked 
data for machine learning. This is semi-supervised learning. 
The basic idea of semi-supervised learning is to use the model assumptions on the data 
distribution to create a learner to label unlabeled samples. 
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From the perspective of the sample, the semi-supervised learning problem is machine 
learning using a small number of labeled samples and a large number of unlabeled 
samples. From the perspective of probability learning, it can be understood as a study 
of how to use the correlation between the input edge probability and the conditional 
output probability of the training sample. Classifier. The existence of this connection is 
based on certain assumptions, namely the cluster assumption and the manifold 
assumption. 
Multiple Instance Learning: The data is tagged, but the target of the tag is not 
a sample, but a packet. When the mark of a bag is negative, the mark of all samples in 
the bag is negative. When a bag is marked positive, at least one of the samples in the 
bag is marked as positive. Our goal is to learn to get a classifier so that the positive and 
negative signs can be given to the newly entered sample. One such type of problem is 
the multiple example problem. For example, to do detection problems, when marking 
the training picture sample, you need to give a rectangular box to indicate the position 
of the target. It is possible that the target is not accurate enough, resulting in different 
samples being misaligned. At this time, the marked rectangular frame can be partially 
disturbed. Get some new rectangles and think of them together as a bag, where there is 
always one that is the best positive sample, which is marked as positive. And take a 
picture without a target, as a negative sample package: no matter how the picture is 
intercepted inside, it is a negative sample. 
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CHAPTER 3. Machine Learning 
Models for Multi-parametric 
Glioma Grading With Quantitative 
Result Interpretations 
3.1. Abstract 
Gliomas are the most common primary malignant brain tumors in adults. Accurate 
grading is crucial as therapeutic strategies are often disparate for different grades and 
may influence patient prognosis. This study aims to provide an automated glioma 
grading platform on the basis of machine learning models. In this paper, we investigate 
contributions of multi-parameters from multimodal data including imaging parameters 
or features from the Whole Slide images (WSI) and the proliferation marker Ki-67 for 
automated brain tumor grading. For each WSI, we extract both visual parameters such 
as morphology parameters and sub-visual parameters including first-order and second-
order features. On the basis of machine learning models, our platform classifies gliomas 
into grades II, III, and IV. Furthermore, we quantitatively interpret and reveal the 
important parameters contributing to grading with the Local Interpretable Model-
Agnostic Explanations (LIME) algorithm. The quantitative analysis and explanation 
may assist clinicians to better understand the disease and accordingly to choose optimal 
treatments for improving clinical outcomes. The performance of our grading model was 
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evaluated with cross-validation, which randomly divided the patients into non-
overlapping training and testing sets and repeatedly validated the model on the different 
testing sets. The primary results indicated that this modular platform approach achieved 
the highest grading accuracy of 0.90 ± 0.04 with support vector machine (SVM) 
algorithm, with grading accuracies of 0.91 ± 0.08, 0.90 ± 0.08, and 0.90 ± 0.07 for grade 
II, III, and IV gliomas, respectively. 
3.2. Introduction 
Gliomas are the most common primary malignant brain tumours in adults, accounting 
for 30% of all primary central nervous system (CNS) tumours and 80% of all malignant 
brain tumours [92]. According to their histopathological characteristics, such as 
cellularity, pleomorphism, nuclear atypia, necrosis, and endothelial proliferation, 
gliomas can be classified into WHO grades I–IV [93]. Correctly differentiating tumor 
grades is critical because they are widely used to predict patient outcomes and 
determine the use of adjuvant therapy protocols including aggressive radiotherapy and 
concomitant chemotherapy [94]. A precise prediction of the prognosis depends on an 
accurate pathology diagnosis. Compared to glioblastoma (GBM), low-grade gliomas 
(LGGs; WHO II) have greater chemotherapy sensitivity and a better post-therapy 
prognosis [95-97]. 
Considered as one of the “gold standards” and conventionally used by pathologists for 
tumor grading, haematoxylin and eosin (H&E) stained images provide specific 
histopathological characteristics and patterns to differentiate gliomas grades [98]. The 
parameters extracted by clinicians from WSIs mostly focused on the cellular level, 
including the number and size of nuclei, which reflects the proliferation and 
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differentiation of the nuclei per unit area and heterogeneity of different levels of the 
tumor cells. For instance, compared to grade II gliomas, grade III, and grade IV both 
exhibit microvascular proliferation (MVP), indicating the presence of proliferation of 
enlarged blood vessels in the tissue [99]. Grade IV gliomas can be further distinguished 
from grade III by examining H&E stained images for the presence of highly 
pleomorphic cells with hyperchromatic, irregular nuclei and brisk mitotic activity. 
Grade IV gliomas are often more mitotically active, necrosis prone, and generally 
associated with neovascularity, infiltration of surrounding tissue and a rapid 
postoperative progression [9]. However, the conventional grading procedure based on 
H&E pathology images is often subjective and operator-dependent and of low 
reproducibility due to the inter-observer variability. 
Apart from H&E stained images, immunocytochemical staining with Ki-67 antibodies 
has been widely accepted as an alternative reference for assessing the proliferative 
potential in tumor cells. Strictly associated with cell proliferation, Ki-67 nuclear antigen 
is present during all active phases of the cell cycle (Gap 1, Synthesis, and Gap 2 phases 
of the cell cycle) and mitosis but absent in resting (quiescent) cells (Gap 0) [100]. The 
proliferative index (PI), determined by Ki-67 immunohistochemistry (IHC), correlates 
well with the histopathological malignancy grade of gliomas [101]. PI values may assist 
in differentiating grade II from III or grade II from IV; however, due to the overlapping 
PI values of grades III and IV, PI itself would not be considered as sufficient evidence 
to adequately determine these two malignancy grades [101]. 
Computer-assisted grading systems are capable of mining a large number of 
quantitative features from digital pathology slide images to sort out the most important 
patterns for grading. This ability provides the opportunity for better quantitative 
44 
 
modeling of the disease appearance and hence possibly improves the prediction 
accuracy of tumor grading. In addition, it also provides a more reproducible, less labor-
intensive and more efficient mechanism than manual grading by pathologists. However, 
the compelling opportunities offered by big digital pathology data come with optimal 
computational algorithm challenges [102]. For example, image analysis and computer-
assisted detection models inadequately address the data density in high-resolution 
digitized whole slide images (WSI). Mousavi et al. (2015) [103] proposed to distinguish 
LGGs from GBMs using image features extracted from regions of interest (ROIs) in 
WSIs. However, the manual selection of ROI in this method may introduce a potential 
risk of inter-observer variance. Kong et al. (2009) [104] tiled the WSI into non-
overlapping pieces and analyzed each image tile to grade LGGs from GBMs. While 
fully processing all the image tiles, the method might be less computationally efficient, 
in particular, for high-resolution H&E stained images. To improve computational 
efficiency of the automated prognosis of neuroblastoma from H&E images, Sertel et al. 
(2009) [105] proposed a multiresolution approach to extract local binary pattern and 
texture features of different scales. 
While the above mentioned automated methods process and analyze WSIs for grading, 
the method proposed by Ertosun and Rubin (2015) [80] classified LGGs and high-grade 
glioma (HGGs) on the basis of automated segmentation and analysis of cell nuclei and 
morphological features [106] but neglected the tumor patterns important for manual 
grading. To systematically compare the performance of classic machine learning 
models on grading, Huang and Lee (2009) [107] implemented three machine learning 
models, Bayesian, k-nearest neighbors (KNN) and support vector machine (SVM), and 
concluded that KNN and SVM both achieved the highest accuracy. Apart from 
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conventional machine learning, Reza and Iftekharuddin (2016) [108] proposed a deep 
learning-based grading system, characterizing each tile type with convolutional neural 
network (CNN). However, these machine learning and deep learning models are 
considered as “black boxes” without transparent interpretation of either the models 
themselves or the grading results. 
To improve reproducibility and avoid inter-operator variance in conventional manual 
grading, in this study, we design and implement a platform for automated grading 
gliomas into grades II, III, and IV from digital pathology images. In our approach, 
discriminative visual, sub-visual and IHC parameters are identified, and a reliable 
machine learning model is selected. With the machine learning based models, we 
integrate information from both histopathological morphology images and proliferation 
biomarkers into a single unified framework to predict the glioma grade in 116 
patients,which surpass the current clinical paradigm for patients diagnosed with glioma. 
Our platform provides interpretation on the grading outcomes to disclose the 
contributions of multiparametric features to individual cases and presents an alternative 
for objective, accurate, and interpretable prediction of glioma grading in the clinic. 
3.3. Materials and Methods 
The dataset used in this study involves 146 cases of glioma grading from grades II to 
IV: 49 grade II, 45 grade III, and 52 grade IV images. All cases were from Shandong 
Provincial Hospital affiliated to Shandong University, and the pathology diagnoses of 
the cases were based on the 2007 WHO standards [93]. Paraffin-embedded samples 
were cut into three μm thick sections and stained with H&E stain. All H&E images in 
this study were obtained from WSIs scanned by a Leica SCN400 slide scanner (Leica 
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Biosystems, Nussloch, Germany) with multiresolution varying from 20× to 40×. Ki-67 
immunohistochemical staining was prepared using an automated staining instrument 
(Ventana, Benchmark Ultra). As defined in Eq. 1, Ki-67 PI is the percentage of the 
number of immunoreactive tumor cells in relation to the total number of cells. At least 
1000 tumor cells or alternatively, three high-power fields (HPFs) were examined by 
two independent experienced observers. The mean of Ki-67 PI is the average of the 
values calculated by different observers. 
𝑃𝐼 =  
𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝐶𝑒𝑙𝑙𝑠
𝑇𝑜𝑡𝑎𝑙 𝐶𝑒𝑙𝑙𝑠
 × 100 
3.4. Automated interpretable Glioma grading with 
Machine-Learning Models 
As illustrated in Figure 8, our automated grading framework is composed of five major 
components including automated ROI identification, feature extraction, important 
feature selection, automated grading, and result interpretation. 
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Figure 8 Schematic flowchart of the automated grading framework. We first 
automatically selected the representative regions of interest (ROIs) from the H&E 
images. Based on these ROIs, we extracted and selected important visual, sub-
visual, and immunohistochemically features. We established automated machine 
learning models with these features for glioma grading. The grading results output 
from the model were further explained with the LIME algorithm. 
3.4.1. Automated ROI Identification 
Our proposed computational method automatically identifies the ROIs that reflect cell 
proliferation and cellular density based on the number of nuclei in the regions. H&E 
images were first partitioned as tiles, each with a resolution of 5120∗5120 pixels to 
enable the process of high-resolution imaging [104, 109]. Then, we detected nuclei 
using watershed nuclei detection algorithm in each tile [110, 111] and based on the 
density of the detected nuclei, the five tiles with the highest densities of nuclear were 
identified as the ROIs. 
3.4.2. Multi-Parameter Extraction and Important Parameter Selection 
From the identified ROIs, we extracted multi-parameters including visual features and 
sub-visual features as the inputs for automated grading. The visual features, including 
seven nuclear morphological features, five nuclear staining features, and nuclei clusters 
or patterns, were extracted to reflect a basis for observation when pathologists make 
diagnostic decisions [106]. For instance, nuclear morphological characteristics such as 
shape, size, and circularity that reflect cellular atypia have been commonly used by 
pathologists to distinguish different grades of glioma. 
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In addition to the visual features, sub-visual features also contribute to accurate glioma 
grading. The sub-visual features are the computerized high-throughput intensity and 
texture image features that have been proved to have diagnostic, predictive, and 
prognostic power, although these features are somehow beyond human perception 
capabilities [112]. In our method, for instance, intensity features describe the first-order 
statistical information of the image intensity distribution, while the second-order grey-
level co-occurrence matrix (GLCM) features capture both statistical intensity and 
relationship between neighbourhood pixels, revealing information such as homogeneity, 
contrast and entropy [113]. As illustrated in Figure 6, we used a random forest (RF)-
based feature selection method combined with backward feature elimination to choose 
the most representative and informative features [114]. 
3.4.3. Machine Learning Model for Automated Grading 
To select the best machine learning model for grading, we compared the performance 
of four types of classic machine learning models including RF [115], gradient boosting 
decision tree (GBDT) [116], SVM [117] and neural network (NN) [72, 118, 119]. To 
achieve the best performance for each grading model, the hyper-parameters of the 
model need to be optimized, for example, the tree number in RF model. The framework 
for automatically tuning the hyper-parameters is provided in Figure 9. 
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Figure 9 Machine learning model with hyper-parameter tuning. The original data 
were randomly separated into training data and testing data. Training data were 
used to train the machine-learning model, while testing data were used to evaluate 
the model performance. The hyper-parameters of the model can be continuously 
tuned with information acquired from testing results until the optimal model is 
obtained. 
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3.4.4. Validation and Evaluation 
The 116 patients out of 146 was used to train the model while the other 30 patients was 
used for further validate the model. The 116 patients were randomly divided into 
training datasets (75%) and testing datasets (25%) to test performance and validate the 
models [120]. The corresponding training set was used to train the classifier, and the 
test set was used to verify the model performance. This procedure was repeated 30 times 
by changing random states while maintaining the same train-test split ratio. Apart from 
accuracy, other measurements including precision, recall, F1 score and confusion 
matrix were calculated to more completely validate grading performance. In addition, 
extra 30 cases were used as validation dataset with 30 times of cross-validation to 
further test the performance of our proposed model. 
3.5. Results 
3.5.1. Multi-Parameter Extraction and Selection 
In the multi-parameter extraction phase, we extracted 24 visual parameters and 171 sub-
visual parameters. Since the large size of the sub-visual features may suppress 
important morphological features, we performed the feature selection process on the 
sub-visual features twice to eventually choose 15 features from this category. The 
predictive performance of the selected 11 visual features, 15 sub-visual features and 
one IHC characteristic – Ki-67 in this study – were assessed with separate RF models. 
The box-plot in Figure 10A shows that visual features had the highest predictive power 
with 0.76 accuracy, while the accuracy for sub-visual features and Ki-67 only reached 
0.62 and 0.53, respectively. 
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Figure 10 Predictive capability of selected important features and models. (A) 
Predictive accuracy of different categories of selected important features. In each 
category, features were assessed for accuracy separately. (B) Accuracy of different 
grading models. 
3.5.2. Automated Grading Performance with Different Models 
We fed these selected important parameters into the four machine learning models RF, 
GBDT, SVM, and NN to sort out the best grading model. Based on cross-validation, 
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SVM achieved the most accurate and stable grading performance, with the accuracy of 
0.90 ± 0.04, while the other three models had lower but nearly the same performance 
with accuracy stabilized at approximately 0.87 (Figure 10B). Table3 shows the results 
of other measurements including F1, precision and recall, among which the SVM model 
maintained the best performance. 
Table 1 F1, accuracy, precision, and recall for different machine learning models. 
Method F1 Accuracy Precision Recall 
Random Forest 0.86±0.07 0.87±0.06 0.86±0.07 0.87±0.06 
GBDT 0.86±0.08 0.87±0.07 0.86±0.07 0.86±0.07 
Neural 
Network 
0.86±0.05 0.86±0.06 0.87±0.06 0.87±0.05 
SVM 0.90±0.07 0.90±0.04 0.91±0.04 0.91±0.04 
 
3.5.3. Further Investigation of SVM Performance 
To better understand the performance of the SVM model for grading histologic grades 
of glioma II, III, and IV, we calculated a confusion matrix to uncover misclassification 
cases. As illustrated in Figure 11A, grade II had the highest accuracy (0.91) in the SVM 
model while the other two grades both had the accuracy of 0.90. As shown in the 
confusion matrix for the SVM model (Figure 11B), grade III gliomas may share 
common histological characteristics with both grade II and grade IV gliomas and 
thereby may lead to misclassification. In addition, we added 30 new patients of grade 
54 
 
II to IV for the further validation. The validation performance achieved 0.88 ± 0.14 with 
30 times cross-validation. 
 
Figure 11 Assessment of grading results with the support vector machine (SVM) 
model. (A) Prediction accuracy for different histological grades in the SVM model. 
The accuracy for each grade was obtained by separating the results by grades in 
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the 30 times cross-validation. (B) Confusion matrixes for different models. The 
confusion matrixes reveal the number of misclassified cases for each grade. 
3.5.4. Quantitative Grading Results Interpretation 
The machine learning algorithm is usually complex and considered as a “black box” 
without explicit interpretation of the learning process or the outputs. To provide a better 
quantitative interpretable explanation for the grading results, we used Local 
Interpretable Model-Agnostic Explanations (LIME) algorithm [121] to reveal the 
importance of features and their underlying contribution to the grading decision. In this 
section, we illustrated three case studies to interpret the automated grading results and 
the underlying reasoning for our SVM model with the LIME algorithm. 
As Ki-67 has been proved to be a clinically significant indicator for grading, we 
predicted the grading results by machine learning models while also taking the 
influence of Ki-67 into consideration. To highlight this strategy, we chose three cases 
to elucidate the workflow of SVM for precise grading. As shown in Figure 12A, Case 
1 is a relatively easy case to classify, being grade II with low Ki-67 (0.05). However, 
Case 2 and Case 3 are more ambiguous, both with a value of 0.2 for Ki-67, but one is 
grade III while the other is grade IV. We established a result explainer with LIME 
algorithm for the SVM model and then calculated the feature contribution for each case. 
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Figure 12  Grading result explanation of representative cases with the LIME 
algorithm for the SVM model (part 1) (A) Distribution of Ki-67 by different grades. 
Three selected cases had Ki-67 PI values of 0.08, 0.2, and 0.2. (B) Prediction 
probability for three cases. 
Case 1 (Figure 12C) was correctly classified as grade II with a high probability. As Ki-
67 has been clinically proved to have the discriminative capacity to distinguish between 
LGG and HGG, it is not surprising that Ki-67 has the dominant influence underlying 
this correct decision. Apart from Ki-67, visual features such as cell pattern and sub-
visual features such as GLCM texture features also can correctly guide the grading. The 
result also shows that although some morphological features such as perimeter do not 
support the decision of grade II, they excluded grade III, which also contributed to 
accurate grading. 
For the more ambiguous Case 2 (Figure 13) and Case 3 (Figure 14), with regard to Ki-
67 itself, our classification model demonstrated its capability for an accurate decision. 
Case 2 (Figure 13) was the most challenging case among these three cases because in 
this case, Ki-67 had only a negative influence on the grading decision; however, with 
the strong support of GLCM texture features and the morphological nuclei count feature, 
our grading system made a correct decision. In Case 3, Ki-67 was the major contributor 
to the correct decision, while the morphological features such as standard deviation of 
cells’ max axis and standard deviation of cells’ perimeter were the second and third 
contributors. 
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Figure 13 Grading result explanation of representative cases with the Local 
Interpretable Model-Agnostic Explanations (LIME) algorithm for the SVM model 
(part 2) (A) Glioma Case 2 for grade III with Ki-67 PI value of 0.2 while texture 
features and morphological nuclei count feature were the major contributors.  
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Figure 14 Grading result explanation of representative cases with the Local 
Interpretable Model-Agnostic Explanations (LIME) algorithm for the SVM model 
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(part 3) (B) Glioma Case 3 for grade IV also with Ki-67 PI value of 0.2 accounting 
for the dominant contribution. 
3.6. Discussion 
Given the well-recognized difficulties associated with the grading of gliomas, in this 
study, we developed an automated and interpretable grading of gliomas with a machine-
learning platform to provide an additional reference for diagnostic decision-making and 
patient management and prognosis, which is more efficient, effective, and objective 
than currently used methods. Our major findings were that (1) our method achieved a 
high grading accuracy of 90% for classifying gliomas into grades II, III, and IV; and (2) 
more importantly, for the first time, an interpretable insight into the grading outputs 
was provided for the histology grading system with the “black-box” machine learning 
models. 
Computerized image perception in tissue histology is much more difficult due to the 
complexity of the cell patterns and inherent structural associations between different 
tissue components. Accurate histopathological diagnosis determines patient 
management, treatment, and follow-up, so any method that results in more objective 
glioma grading may be of great value. In the current literature, automated grading either 
was based on texture patterns extracted from the selected ROIs [103] to capture the 
histological structures in the histological images or utilized morphological features 
extracted from segmented tumor cells [80, 105]. Our method achieved high accuracy 
through fully utilizing the selected informative visual and sub-visual features from 
H&E images combined with the Ki-67 PI value. To take into account the visual cues 
used by pathologists for manual grading, visual features such as texture patterns and 
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cell morphological characteristics were extracted from selected ROIs. The sub-visual 
features that are beyond human perception capacities can help the precise grading 
through quantitative analyses that are more comprehensive. Furthermore, we 
innovatively integrated the IHC indicator Ki-67 PI into our grading platform, which 
contributed to boosting our grading accuracy with high discriminatory power. 
Generally, the aim of this research was to objectify, standardize and quantify features 
that are already widely accepted as important by pathologists. Inter-observer 
discrepancies, which had long been a diagnostic problem in the past, could be partly 
overcome by employing the morphometric analysis used in the present study [122]. The 
ability of the system to objectively identify regions of tumor may additionally 
complement the pathologist’s diagnosis and assist in tailored treatment. In this study, 
we attempted to automatically clarify the cellular composition and histopathological 
features of different grades of gliomas by utilizing morphometric- and 
immunohistochemically-based machine learning models. We assessed the importance 
of visual features, sub-visual features and Ki-67 separately, and the highest predictive 
power was achieved by visual features, achieving an accuracy of 0.76, which indicates 
that the histomorphology of glioma, such as nuclear morphological features and nuclear 
staining features and patterns play an important role in glioma grading. 
The interpretability of the individuals’ grading results provided quantitative insights 
into the feature contributions of each individual case. Most of the grading systems based 
on machine learning models are considered “black boxes,” and it would be valuable for 
patient management if clinically trusted reasoning could be revealed. In our study, we 
used the LIME algorithm to provide an explanation for each individual grading result. 
Case 1 and Case 3 in Figure  12C and Figure 14 endorse the important role that Ki-67 
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plays in grading decisions, which is in accordance with the clinical fact that Ki-67 PI is 
positively correlated with the histopathology grades [123]. However, Ki-67 sometimes 
has a detrimental influence on the grading process, as shown in Case 2, because Ki-67 
PI of grade III gliomas largely overlaps with that of grade IV [101, 124-126]. As a result, 
Ki-67 itself cannot be the only determinant of grading. It has been accepted that the Ki-
67 PI value is 3.0 ± 2.1% in grade II gliomas, 11.8 ± 3.4% in grade III anaplastic gliomas 
and 15.8 ± 7.4% in grade IV GBMs [126]. Furthermore, the Ki-67 PI values of grade 
III anaplastic glioma can overlap with values of grade II glioma at one end of the range 
and with those of GBM at the other in the diagnostic practice of pathologists. Apart 
from Ki-67, morphological features including the standard deviation of cells’ max axis 
and perimeter were also found to be a significant contributor to glioma grading because 
HGG often exhibits strong heterogeneity with irregular cell shapes [9, 127]. The precise 
morphological features extracted from the most aggressive regions help to investigate 
intratumoral histological heterogeneity for precise histopathology grading [128]. The 
primary grading results still support the conclusion that the only sure way to determine 
the histopathological WHO grade remains the histopathology evaluation of the H&E 
stained tumor sample [129]. 
With three representative cases we could gain a deeper understanding of why 
misclassified grade III cases are often labelled as grade II, while grade IV cases could 
be wrongly labelled grade III as shown in the confusion matrix. Actually, the Ki-67 PI 
values of the GBM group can be as low as those for grade II tumours, indicating the 
limitation of Ki-67 values in the overlap region. In our work, we introduced a number 
of histological sub-visual features such as the intensity and GLCM texture features to 
distinguish these three grades of gliomas. These insights become easy once it is 
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understood what the algorithm models are actually doing, which in turn leads to models 
that generalize much better results. In many applications of machine learning, users are 
asked to trust a model to help them make decisions. There has always been a focus on 
“trust” in any type of modelling methodology, but with machine learning, many people 
feel that the black-box approach taken with these methods is not trustworthy. Through 
this machine learning-based approach, we could use the LIME algorithm to explain 
individual predictions to the decision-maker (the pathologist), and that understanding 
of the model’s predictions can be an additional useful tool when deciding whether a 
model is trustworthy or not for the final diagnosis from a pathologist. 
Our study did, however, have its limitations. First, grade I gliomas are not included in 
our studies. They are accurately considered benign in clinical practice, in that complete 
surgical excision is considered curative. Therefore, grade I gliomas are different from 
grade II-IV gliomas in biological behaviour. The results of our discrimination of grade 
III and grade IV are just reasonable preliminary results but leave much room for 
improvement. Considering that necrosis is one of the remarkable features of GBM, we 
plan to use cell necrosis as an input feature to further train models to distinguish grade 
III from grade IV GBM. Actually, morphometric data research has indicated that the 
cellularity of oligodendroglia’s type II was significantly higher than that of diffuse 
astrocytoma’s and that the conditional entropy of oligodendroglia’s type III was 
significantly lower than that of diffuse astrocytoma’s [123] so further stratification of 
LGG (grade II) will lead to tailored glioma management according to their different 
biological behaviour. Hence, future work will focus on improvements utilizing larger 
datasets, including multi-centre cases. In addition, there is still much room to improve 
the grading performance and generalization of the algorithm model. 
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3.7. Chapter summary 
In conclusion, our approach provides an objective alternative for quantitative pathology 
research and for the implementation of morphological data in routine diagnostic 
practice. The machine-learning model utilized multi-parameters including 
morphometric and sub-visual parameters as well as Ki-67 PI information to ensure high 
accuracy, efficiency and consistency in glioma grading. Interpretable grading platform 
has the potential to facilitate personalized medicine in the setting of malignant gliomas. 
With different important features identified for different patients, specific phenotypic 
tumor characteristics can be uncovered for optimal treatment selection. In addition, as 
our method is fully automated and quantitative with high reliability, it becomes easier 
for our platform to be introduced in routine clinical practice. 
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CHAPTER 4. RA-PA-Thomics: A 
new approach to glioma genotype 
prediction  
4.1. Abstract 
Glioma is the common primary brain tumor in adults. Preoperative identification of 
isocitrate dehydrogenase 1 (IDH1) mutations in gliomas may aid the classification of 
glioma and predict the clinical outcome. In this study, we aim to integrate multi-modal 
biomedical imaging information comprising both magnetic resonance image and digital 
histopathological scans, to predict IDH1 phenotypes and improve the accuracy. To deal 
with the multi-modal biomedical images, we have developed an automated framework 
for fast and cost saving IDH1 phenotypes prediction. Data from 217 histopathological 
diagnosed glioma patients were used. In contrast to most studies that solely relied on 
MRI radiomics features to predict glioma IDH1 phenotypes, we have also included 
digitized histopathological data to enhance the accuracy. Firstly, a random forest (RF)-
based algorithm was used to identify and quantitatively analyze features in multi-modal 
biomedical images of radiological (RA) and pathological (PATH) origin. Then we 
integrated these RA- and PATH-omics data employing a machine-learning algorithm 
(Random Forest) to test the performance of IDH1 genotyping. We found that RF-based 
machine-learning model, which succeeds in using a combined pattern of RA and PATH 
images, is capable of predicting IDH1 phenotypes with high accuracy and reliability. 
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This combination-based prediction algorithm, RA-PATH-omics, is a supplement to the 
previous method. Accuracy achieved was 0.90 with multi-model medical images 
compared to 0.78 (brain tumor segmentation from the multi-slices FLAIR  MR images), 
0.68 (edema extraction from the FLAIR images), 0.72 (brain tumor segmentation from 
the T1CE MR images) and 0.73 (the edema area segmentation from the T1CE MR 
images), respectively, 0.82 for radiomics features alone and 0.86 for PATH-omics 
features. The integration of RA-PATH-omics in a single combined machine-learning 
model provides a new way of predicting glioma IDH1 phenotypes with great accuracy. 
The new method could thus be useful as a routine screening procedure for patients who 
do not have easy access to the lab IDH1 genotyping. 
4.2. Introduction 
Based on studies and clinical researches, the  2016 WHO classification has considered 
two more molecular anomalies included isocitrate dehydrogenase (IDH) and 1p/19q 
into adult glioma diagnostics [9, 130]. Competing with single histopathology character, 
genotype features in molecular level can achieve a higher accuracy of the classification 
and better prediction of clinical outcome [9]. According to recent researches, key 
molecular markers like IDH mutation plays a dominated character in the description of 
brain tumors. Because the molecular diagnosis is part of the diagnostic classification, 
clinical doctors suggest that gliomas with IDH mutation may have more value for 
diagnostic and prognostic [32, 131]. Therefore, accurate IDH genotype prediction paly 
a dominated role in the prognosis of glioma patients. 
Histopathology images have been brought into clinical cancer research and 
conventionally used by pathologists in the area of tumor grading [132-134]. In addition, 
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pathologists can observe the cellular and sub-cellular level features from whole slide 
images [81]. However, for the IDH genotyping, recent researches have more focused 
on the analysis of the multimodality MRIs. Therefore, compared with most of the 
current experiments, we have included pathological images in this experiment. 
Although current predictions are increasingly dependent on different genomic 
biomarkers, histology continues to play an important role in predicting disease 
progression in glioma patients. Because, compared to radiology, histology reflects a 
variety of information at the cellular level. However, competing with computational-
aid imaging diagnoses, the traditional method by different pathologists are much more 
subjective and unreproducible. Computationally imaging analysis based on histology 
images can reduce the bias between different pathologists [31, 135, 136]. 
Machine learning algorithms are currently widely used in glioma research, and most 
are based on the analysis of features extracted from MRIs [135, 137-139]. 
Computationally biomedical imaging analysis could mine massive features from 
multimodality images for IDH genotyping. Zhou et al. [28] proposed to distinguish the 
IDH genotype with primary grade II and III glioma using clinical and pathological 
variables and textures features extracted from region of interest (ROI) in four sequences 
of MRI, including T1W，T2W，T1CE and T2F, which reached the accuracy of 0.86. 
Competing with the method mentioned by Zhou, Eichinger et al. [140] have designed 
local binary pattern texture features for IDH genotyping, which increase the accuracy 
to 92%. Apart from the traditional machine learning algorithm, the method proposed 
by Xing et al. [141] classified IDH mutation and IDH wild type (IDHwt) using 
conventional machine learning algorithm to extracted deep features from 4 sequence of 
MRI (T1W，T2W，T1CE，T2F). 
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As mentioned before, there are many researches have focused on lower-grade gliomas. 
Zhang et al. [31] aims to distinguish IDH mutation and IDHwt by the primary grade III 
and IV glioma with important features (age, intensity, texture and shape features) 
extracted from multimodality MRIs (T1, T1c, T2, T2/FLAIR and DWI), which the 
accuracy arrived at 0.8830 with random forest algorithm.  
In this study, we predict the IDH genotype based the preoperative MRIs and whole slide 
images of patients diagnosed with low- and high-grade gliomas. In our research, the 
integration of WSIs, multimodality MRIs and clinical information via the machine-
learning algorithm help us to improve the accuracy of IDH genotyping. Through the 
machine-learning algorithm, we combine the different modality of biomedical images 
into a single framework for IDH prediction. 
4.3. Materials and Dataset 
4.3.1. Patient Enrolment 
The imaging data of 217 subjects with glioma were collected from two different sources. 
126 cases were from Shandong Provincial Hospital Affiliated to Shandong University, 
comprising 41 histological grade III cases and 85 histological grade IV cases. The 
remaining 91 cases were retrieved from The Cancer Imaging Archive (TCIA), 
comprising 25 histological grade III cases and 66 histological grade IV cases (Table 2). 
The criteria for image acquisition in this study are as follows: (I) available histology, 
age at diagnosis and sex, and IDH1 status; (II)MR imaging data, including post-contrast 
T1-weighted images (T1CE), and T2-FLAIR, and (III) histopathological images. 
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This study was approved by the institutional review board of Shandong Provincial 
Hospital affiliated to Shandong First Medical University (NSFC NO: 2019-272), and 
the informed consent requirement was waived from each enrolled patient. 
Table 2 Patient Characterizes 
 Shandong provincial hospital TCGA 
Grade III (n; %) 41 25 
IDH-mutated in Grade 
III (n; % column) 
20, 48.9% 17, 68% 
Grade IV (n; %) 85 66 
IDH-mutated in Grade 
IV (n; % column) 
20; 23.5% 12, 18.2% 
Age (years; mean; 
range) 
49; [5, 79] 53; [18, 81] 
Sex (n male; % column) 55; 43.7% 55; 60.4% 
4.3.2. Dataset 
4.3.2.1 Imaging Data Acquisition and Pre-processing 
Histopathological Images: Shangdong provincial hospital’s cohort: Cases 
were diagnosed according to WHO criteria [142]. Paraffin-embedded samples were cut 
into three μm thick sections and stained with H&E stain for all patients in this cohort. 
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All H&E images were scanned by a Leica SCN400 slide scanner (Leica Biosystems, 
Nussloch, Germany) with multi-resolution varying from 20× to 40× for analysis.  
Genomic DNA was isolated was performed to enrich for neoplastic cells from 
formalin-fixed paraffin-embedded glioma tissues. DNA was extracted using the 
QIAamp DNA micro kit (Qiagen GmbH, Hilden, Germany) as previously described 
[143]. 
Expression of IDH1-R132H mutant was firstly analyzed by IHC as previously 
described [144]. IDH1 and IDH2 gene mutations were identified by Sanger sequencing 
[145]. IDH status was defined according to the absence of IDH1-R132H 
immunopositivity and/or mutations in IDH1 and IDH2 genes. 
The Cancer Genome Atlas cohort: Digital pathology slides diagnosed of diffuse 
glioma were downloaded from The Cancer Genome Atlas (TCGA) Data Portal 
(http://cancergenome.nih.gov.) with IDH status, and the corresponding MRI images 
were acquired from the The Cancer Imaging Archive (TCIA) Data Portal 
(https://www.cancerimagingarchive.net).   
Multimodal MR Images: All patients were imaged in the supine position with 
a 3.0-T MRI machine (Magnetom, Skyra; Siemens Healthcare, Erlangen, Germany) 
using a transmit/receive quadrature 20-channel head-and-neck coil. The imaging 
protocol was the same for all patients. 
T1-contrast: TR: 1820 ms, TE: 13 ms, slice number: 19, FOV: 230 mm, slice 
thickness: 5 mm, distance factor: 30%, FA: 150 deg, inversion time (TI): 825 ms, voxel 
size: 0.4×0.4×5.0 mm, accelerate factor: 2, bandwidth: 260 Hz/Px, echo spacing: 13 ms. 
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Fluid-attenuated inversion recovery imaging (T2-FLAIR): TR: 8000 ms, TE: 81 
ms, slice number: 19, FOV: 220 mm, slice thickness: 5 mm, distance factor: 30%, FA: 
150 deg, inversion time (TI): 2370 ms, voxel size: 0.7×0.7×5.0 mm, accelerate factor: 
2, bandwidth: 289 Hz/Px, echo spacing: 9.02 ms. 
All MRI sequences of each patient from our own datasets and from TCIA have 
the same imaging scale, position，slices and slice thickness. 
4.4. Computer Analysis 
An automated framework was designed to predict IDH1 genotype, consisting of the 
following steps, which were carried out in sequence: (I) automated image pre-
processing to select the regions of interest (ROIs), (II) feature extraction, (III) feature 
selection, and (IV) automated IDH1 genotype prediction and results interpretation. 
(Figure 15) 
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Figure 15 Machine learning framework for automated prediction of IDH 
glioblastoma genotypes. Representative regions of interest (ROIs) are selected on 
multimodal MR and histopathological images, respectively. After that, 
histopathological and radiomics features were derived from the ROIs. Then, in 
order to reduce the redundant features, the Random Forest model based 
Recursive Feature Elimination (RF-RFE) algorithm was adopt to select the 
relevant features. Following 10-fold cross-validation, the automated machine-
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learning model with relevant features for glioma IDH genotype prediction is 
established. Abbreviations: GCLM, Grey Level Co-occurrence Matrix features; 
GLRLM, Grey Level Length Matrix features; GLSZM, Grey Level Size Zone 
Matrix features; NGTDM, Neighboring Gray Tone Difference Matrix features; 
GLDM, Grey level Dependence Matrix features. mass of features, which may have 
redundant information, are selected and processed improving the predictive 
power of the machine-learning model. 
4.4.1. ROI Extraction 
Our computational algorithm used for the analysis of histological images approaches 
the region of interest at two different levels. First, one tile with the highest cell density 
(5120 * 5120) [105, 109] is extracted employing the watershed nuclei detection 
algorithm [111, 146, 147]. Then, based on Hue, Saturation, and Value of Brightness 
(HSV channel), five tiles representing the whole image [111, 146] at 40X resolution are 
identified. Third, based on the HSV channel, five tiles representing the entire image at 
4X resolution are identified. 
For the analysis of radiological images, we have segmented edema and non-enhanced 
tumors from T2-FLAIR image. In addition, T1CE images were used for enhancing 
tumor volume segmentation. The lesions were separated into three parts, enhancing 
tumor, tumorous necrosis and peritumoral edema. The process of tumor segmentation 
was performed manually using the ITK-SNAP software (version 3.6.0; 
www.itksnap.org). Firstly, all the MRI sequences were retrieved from the Picture 
Archiving and Communication System (PACS). Then we applied N4 bias field 
correction to remove the presence of low frequency intensity non-uniformity. 
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Intermodality co-registration with different 2D MRI sequences was achieved by means 
of ITK-SNAP. Using this method, ROIs of enhancing tumor were delineated on post-
contrast T1WI images by a semi-automatic method, in which only the enhancing area 
was selected. Tumor necrosis was defined as the non-enhancing area within enhancing 
area on post-contrast T1WI. ROIs of peritumoral edema were delineated on T2-FLAIR, 
which was defined as the high-signal region beyond the enhancing area. The process 
was performed by a consultant neuro-radiologist. Finally, the ROIs were registered on 
each slice of each 2D MRI sequence. 
4.4.2. Feature Extraction 
Our computational algorithm used for the analysis of histological images approaches 
the region of interest at two different levels. First, one tile with the highest cell density 
(5120 * 5120) [105, 109] is extracted employing the watershed nuclei detection 
algorithm [111, 146]. Then, based on Hue, Saturation, and Value of Brightness (HSV 
channel), five tiles representing the whole image [1, 111, 146] at 40X resolution are 
identified. Third, based on the HSV channel, five tiles representing the entire image at 
4X resolution are identified. 
For the analysis of radiological images, we have segmented edema and non-enhanced 
tumors from T2-FLAIR image. In addition, T1CE images were used for enhancing 
tumor volume segmentation. The lesions were separated into three parts, enhancing 
tumor, tumorous necrosis and peritumoral edema. The process of tumor segmentation 
was performed manually using the ITK-SNAP software (version 3.6.0; 
www.itksnap.org). Firstly, all the MRI sequences were retrieved from the Picture 
Archiving and Communication System (PACS). Then we applied N4 bias field 
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correction to remove the presence of low frequency intensity non-uniformity. 
Intermodality co-registration with different 2D MRI sequences was achieved by means 
of ITK-SNAP. Using this method, ROIs of enhancing tumor were delineated on post-
contrast T1WI images by a semi-automatic method, in which only the enhancing area 
was selected. Tumor necrosis was defined as the non-enhancing area within enhancing 
area on post-contrast T1WI. ROIs of peritumoral edema were delineated on T2-FLAIR, 
which was defined as the high-signal region beyond the enhancing area. The process 
was performed by a consultant neuro-radiologist. Finally, the ROIs were registered on 
each slice of each 2D MRI sequence. 
4.4.3. Feature Selection 
Although a large number of image features can be used to construct a model that fully 
reflects the characteristics of gliomas, removing redundant information can improve the 
efficacy of the model for glioma genotyping [148]. In order to reduce the amount of 
redundant information inherent to quantitative features, we built a random forest 
algorithm enhanced by a recursive feature elimination (RF-RFE) procedure in order to 
identify the relevant and important characteristics before implementation in a 
classification model all [114]. As shown in Figure 15, the feature with the lowest 
importance for classification calculated by the algorithm will be eliminated.   
4.4.4. Modelling and Validation  
We are proposing a binary classification model to differentiate patients with an IDH1 
mutation from wild type HGGs based on clinical features (age and sex), digital 
histopathological image Pathomics features and MRI Radiomics features. In order to 
achieve this, the Random Forest algorithm was adopted, which is already widely used 
76 
 
in medical imaging analysis. The random forest model can deal with a huge feature set, 
especially the data involved in this study, which can obtain satisfactory results. All 
machine-learning methods were implemented with the Statistics and Machine Learning 
package on Python 3.6. 
In addition, 10-fold cross-validation was utilized to evaluate the performance of the 
machine-learning model: cases were first divided into 10 cohorts, where one of the 
cohorts was used as the testing set and the other 9 cohorts were used for training. 
Specific, in the first iteration, the first cohort was used as the testing set and the rest 
cohorts were used as the training sets. In the second iteration, the second cohort was 
used for testing and the rest cohorts were used for training. This procedure was repeated 
untiled the each cohort of 10 cohorts have been used as testing set. The average 
performance of each iteration was used to evaluate the stability of the prediction model. 
4.5. Results 
4.5.1. Feature Extraction and selection 
In this phase, we have extracted a total of 22 morphological features, which were 
identified in the glioma cases studied (Supplementary Materials I. Histopathologic 
Features Extraction), including nuclear shape and staining intensity (Figure 16), such 
as the mean of nuclei perimeter, area, and solidity. On the other hand, we have extracted 
171 sub-visual features [1] from the high resolution of digital histopathology images, 
including intensity features, GLCM features, etc. As for results of IDH1 status 
prediction for HGGs, the histopathological features extracted from histopathology 
images, which reached an accuracy of 0.81 ± 0.03 with 10-fold cross validation.  
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Figure 16 Feature extraction from histopathological images. Based on two 
different ROI extraction criteria, HSV (Hue, Saturation and Value of Brightness) 
and cell density, six ROIs in total per section presenting different resolutions are 
used. Subsequently, two types of features are extracted from these ROIs as shown, 
visual features and sub-visual features. The latter are derived from histopathology 
images at different resolutions. Visual features from the representative tile with 
the highest density of nuclei were obtained at 40X resolution, with density 
referring to the semantic level and features comprising  both  counts and sizes of 
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individual nuclei. In contrast, sub-visual features were derived from ROIs at 4X 
resolution and included high-throughput intensity and texture image features.  
Turns to multimodal MRIs, 1132 features in all were obtained from each patients and 
each sequence, including 234 first order features, 14 shape-based features, 286 grey 
level co-occurrence matrix features, 208 grey level run length matrix features, 208 grey 
level size zone matrix features, 182 grey level dependence matrix features (Figure 17). 
For HGGs, after feature selection phase, for T1C and T2F, four and five features were 
remained. Based on 10-fold cross validation, we fed the selected features into random 
forest model to predict IDH genotype, which achieved the accuracy of 0.75 ± 0.02 and 
0.71 ± 0.03 separately. 
In this research, we did IDH genotyping prediction for HGGs. The AUC for features 
extracted from different histopathologic grade of biomedical images were 0.90±0.09. 
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Figure 17 Measurements obtained from different regions of individual MR images. 
Briefly, the initial segmentation was performed by a clinicians who identified 
enhancing tumor, non-enhancing tumor and edema. Subsequently, quantitative 
radiomics features were derived from multiple volumes of interest (VOIs). The 
VOIs were divided into seven classes (see : first-order statistics features, shape-
based features, GLCM, GLRLM, GLSZM,  NGTDM, and GLDM features. 
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4.5.2. Comparison of Performances Using Different Modalities of Biomedical 
Images and Feature Types 
In order to evaluate the role of different modalities of biomedical images (T1C, 
T2/FLAIR and WSIs) in the prediction of IDH genotype, random forest machine-
learning model with 10-fold cross-validation was adopted in our research. In general, 
scans of histopathological images have better results in IDH genotype prediction than 
other images (Figure 18C). As for quantitative features obtained from different 
modalities of biomedical images, the Visual features show high accuracy and stability 
(Figure 18 B). 
 
Figure 18 Random forest classifier scores for IDH1 genotype prediction. A, 
Prediction results based on Clinical data (age and gender); B, Prediction results 
based on different feature types; C, Prediction results based on different image 
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modalities; D, Receiver Operating Characteristic (ROC) for IDH genotype 
prediction across multi-parametric medical images. 
4.5.3. Univariate Feature Analysis 
For IDH1 genotype prediction, optimal features were selected from the different 
modalities of medical images, including 7 features from the digital histopathological 
images, 4 features form the T1CE images and 5 from the T2-FLAIR images. As shown 
in Figure 18B, GLRLM, Shape-based and GLCM features had the greatest power in 
predicting HGGs IDH1 status. Age, nuclei counts and first-order features were the most 
important factors that contributed to this result. As summarized in Table 3, top-
performing features within different types of image features contributed to IDH1 status 
prediction as shown. 
Table 3 TOP-performing features in IDH1 Status Prediction by means of 
Univariate Analysis 
Types  Mask Feature Name Feature Description Accuracy 
Clinical N/A Age Age at diagnose; 0.74 
Intensity T1C-
edema 
Uniformity Formula: 
𝐹𝑢 =  ∑ 𝑝(𝑖)
2
𝑁𝑔
𝑖=1
 
0.69 
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Where p(i)  refers to the 
features calculated form Ng 
discrete pixel levels. 
Measuring the sum of the 
square of image VOI pixel 
value. 
Shape FLAIR-
edema 
Flatness Formula: 
𝐹𝑓𝑙𝑎𝑡𝑛𝑒𝑠𝑠 =  
λ𝑙𝑒𝑎𝑠𝑡
λ𝑚𝑎𝑗𝑜𝑟
  
Where λ𝑚𝑎𝑗𝑜𝑟  and λ𝑙𝑒𝑎𝑠𝑡  refer 
to the length of the 
maximum and minimum 
principal component axes, 
respectively. 
Measuring the relationship 
between the largest and 
smallest principal 
components in the VOI 
shape. 
0.67 
Texture T1C-
tumor 
wavelet-
LLL_glrlm_
LRLGLE 
Formula: 0.72 
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𝐹𝐿 =  
∑ ∑
𝑃(𝑖, 𝑗|𝜃)𝑗2
𝑖2
𝑁𝑟
𝑗=1
𝑁𝑔
𝑖=1
𝑁𝑟(𝜃)
 
Where 𝑁𝑔  refers to the gray 
level distribution within the 
VOI, 𝑁𝑟  refers to the 
maximal length within the 
VOI, 𝑃(𝑖, 𝑗|𝜃)  refers to the 
run length matrix for an 
arbitrary direction 𝜃, 𝑁𝑟(𝜃) is 
the number of runs in the 
image along 𝜃. 
This feature quantitative 
describes the joint 
distribution of long-run 
lengths with lower gray level 
values after a wavelet filter. 
Wavelet T1C-
tumor 
wavelet-
HHH-glcm-
MP 
Formula: 
𝐹𝑀𝑃 = max (𝑝(𝑖, 𝑗)) 
Where 𝑝(𝑖, 𝑗)  is the 
normalized co-occurrence 
matrix. 
0.69 
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Quantify the occurrences of 
the most predominant pair of 
neighboring intensity values 
through a Gray Level Co-
occurrence Matrix after an 
image filter by a high-
frequency wavelet. 
LoG FLAIR-
tumor 
 
Log-glszm- 
SALGLE 
Formula: 
𝐹𝑆𝐴𝐿𝐺𝐿𝐸 =  
∑ ∑
𝑃(𝑖, 𝑗)
𝑖2𝑗2
𝑁𝑠
𝑗=1
𝑁𝑔
𝑖=1
𝑁𝑧
 
Where 𝑁𝑔  refers to the 
distribution values within 
the VOI, 𝑁𝑠  refers to the 
zone sizes quantity within 
the VOI., 𝑁𝑧  refers to refers 
to the zones quantity within 
the VOI, and 𝑃(𝑖, 𝑗)  is the 
size zone matrix. 
Quantify the proportion in 
the mask of VOI by quantify 
the Gray Level Size Zone 
joint distribution of smaller 
size zones with lower gray 
0.65 
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level values after the LoG 
filter. 
Morphol
ogy 
Tile Cell counts Quantitative describes the 
cell intensity in the ROI. 
0.78 
 
The accuracy of IDH1 status prediction was as high as 0.88 ± 0.03 when multi-
parametric features were extracted from different histopathological and radiomics 
images through our implementation of the random forest algorithm. Table 4 reveals the 
features that play important roles in our classification model. As shown in this Table, 
clinical data (sex and age) and histopathological features had a dominant role in our 
classification procedure. 
Table 4 Prediction of IDH1 Genotype Based in High Grade Gliomas. 
Image Modalities Accuracy 
Digital Histopathological Images 0.86 (+/- 0.03) 
T1CE (edema and non-enhanced tumor) 0.73 (+/- 0.06) 
T1CE (enhanced tumor) 0.72 (+/- 0.04) 
T2-FLAIR (edema and non-enhanced 
tumor) 
0.68 (+/- 0.05) 
T2-FLAIR (enhanced tumor) 0.78 (+/- 0.04) 
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Multi-modal Image Data  0.90 (+/- 0.05) 
 
4.5.4. Quantitative IDH1 Status Prediction Results Interpretation 
LIME (Local Interpretable Model-agnostic Explanations) is a tool for facilitating local 
model interpretability. The technique perturbs the input data to understand how the 
predictions are affected. Figure 3 and Figure 4 illustrate two representative cases from 
visual analysis and the machine-learning model. The first case is an IDH1-wt patient 
(Figure 19), who is 43 years old (age at diagnosis), female with a histopathological 
grade IV glioma. The second one is a patient with an IDH1 mutation (Figure 20), who 
is 22 years old (age at diagnosis), male with histopathological grade III glioma. 
 
Figure 19 IDH1 status prediction result explanation of representative cases with 
the LIME algorithm for the RF model (IDH1-Wild type case) 
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Figure 20 IDH1 status prediction result explanation of representative cases with 
the LIME algorithm for the RF model (IDH1-Mutation case) 
Machine learning models taking into account their different contributions, then 
quantitatively combine these functions to predict the results. During model training, the 
LIME model can give weighted coefficients to explain the contributions made by 
different features. The LIME model perturbed the feature values and observed the 
resulted changes in prediction. The predictive ability of this algorithm made the most 
important contribution to achieve a higher weight value of the right. Positive weights 
reflect the increase in the corresponding features may make a positive contribution to 
the IDH1 status prediction. In contrast, negative weights would have negative 
predictive power. As shown in Figure 19 and Figure 20, the feature contribution for 
IDH1 genotyping for two representative cases have been listed, which are derived from 
the LIME model to obtain the linear combination of feature values and weights 
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4.6. Discussion 
The determination of isocitrate dehydrogenase (IDH1) status can help guide clinical 
decision making including post-operative treatment such as radio- and chemotherapy. 
We have developed this framework to integrate two cost saving imaging modalities to 
predict a clinically relevant somatic mutation. Thus, determination of IDH1 phenotypes 
as early as possible during the disease course my guide perioperative counselling, and 
the right choice of treatment option. In this study, we develop a random forest 
algorithm-based genotype classifier that allows the prediction of IDH mutation status 
in glioma patients making use of imaging features derived from pre-surgical MRI scans 
and post-operative digital data obtained from routine H&E slides. The primary results 
show this combined digital platforms will allow very large data sets to be created and 
mined to extract new information for high reliability genotype prediction. 
Going beyond the identification of biomarkers, one of the greatest unmet challenges for 
the successful clinical implementation of AI is to build the bridges that enable 
multiscale imaging integration of radiomics, pathomics into readily available pipelines 
that can transform clinical routine. In this regard, it is very important to integrate two 
cost-effective imaging modalities to make precise key somatic mutation predictions. In 
order to improve the accuracy of IDH1 phenotype prediction before the post-treatment 
plan, visual and sub-visual features extracted from digital histopathological images and 
quantitative radiomics feature extracted from different multimodality MRIs were 
implemented into our RF-RFE feature selection model to select the optimal features for 
further analysis. However, the accuracy of the combined RA-PATH-omics within the 
independent testing set was lower than that of the testing set. The most likely reason for 
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this is the differences in MRI model and scan parameters and in IDH1 mutation rate 
among the different patient cohorts. In an ideal scenario, all patient scans would be 
collected with consistent acquisition parameters, and IDH1 mutation prevalence would 
be the same or similar. However, this would be challenging in practice, as MR scanner 
models and acquisition parameters, as well as the demographics of patient captured 
vary widely from institution to institution. 
Our novel integrated approach, which we have termed RA-PATH-omics, was found to 
be a more accurate predictor of IDH1 genotype than either radiomics or 
histopathological feature recognition alone. RA-PATH-omics characterizes tumor 
properties at different biological scales and meet the need to understand correlations 
between image features, genomics, and clinical outcomes. 
Furthermore, the IDH1 predictive performance of histopathological image analysis was 
found to be superior to T2-FLAIR and T1CE (0.86 vs 0.71, 0.75) in HGGs. Among the 
top histomorphometric features, the mean area of cells and the mean of cells axis were 
most significant, where statistically describe the central tendency of cell shape. (In 
addition, age was a good predictor (Accuracy=0.8)). The top identified features are in 
line with the fact that gliomas with an IDH1 mutation have a more coherent nuclear 
architecture, i.e. they are morphologically less atypical than IDH1 wild type, which is 
associated with ahigher risk of recurrence. Our IDH1 phenotypes prediction achieved 
high accuracy for two reasons: First, we integrated MRIs, digital histopathological 
images and clinical information for IDH1 status prediction. Second, we used a relatively 
data to significantly reduce the number of parameters in the model to avoid overfitting 
while making our model more general. To the best of our knowledge, this study is the 
first to integrate MRI and digital pathology images in a computerized model for 
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predicting IDH1 genotype. It is worth noting that T1CE and T2-FLAIR images 
conferred a higher predictive value than other MR sequences. Our study makes an 
important first step towards achieving the goal of radio-genomic tools be used in a 
clinical setting. 
4.7. Chapter Summary 
Our work is a step towards more effective use of combined Radiomics and Pathomics 
data for genotype prediction by utilizing structural MRI sequences and digital 
pathology images for IDH1 phenotype prediction.  In particular, it should be helpful to 
patients who did not receive molecular diagnosis or for retrospective studies. In a more 
general sense, our results (i) show that machine learning can robustly identify genomic 
features within structural MR imaging and histopathological datasets, (ii) suggest a 
complementary method for the genotyping of gliomas, which is suitable for glioma 
patient screening, and (iii) demonstrate the potential for algorithmic tools within the 
clinic to aid clinical decision-making. Taken together, it is expected that integration of 
multimodality omics in oncology research will become commonplace as technology 
evolves, with significant potential for prognosis prediction and treatment strategies for 
brain tumor management in the future. 
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CHAPTER 5. Conclusions and 
Future Work 
5.1. Conclusions 
In this thesis, we target to integrate quantitative imaging data obtained from multiple 
modalities into mathematical models of tumor prediction response to achieve additional 
insights into practical predictive value.  
Firstly, we proposed an automated machine-learning brain tumor-grading platform to 
investigate contributions of multi-parameters from multimodal data, including imaging 
parameters or features from Whole Slide Images (WSI) and the proliferation marker 
KI-67. For each WSI we extract both visual parameters, such as morphology parameters, 
and sub-visual parameters, including first-order and second-order features. On the basis 
of machine learning models, our platform classifies gliomas into grades II, III, and IV. 
Secondly, a quantitative interpretable machine learning approach (Local Interpretable 
Model-Agnostic Explanations) was proposed to measure the contribution of features 
for single case. Most grading systems based on machine learning models are considered 
“black boxes,” and it would be valuable for patient management if clinically trusted 
reasoning could be revealed. The quantitative analysis and explanation may assist 
clinicians to better understand the disease and accordingly to choose optimal treatments 
for improving clinical outcomes. 
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Thirdly, based on the automated brain tumor-grading platform we proposed before, 
multimodal MRIs have been introduced in our research. A new imaging–tissue 
correlation based approach called RA-PA-Thomics was proposed to predict the IDH 
genotype. Inspired by the concept of image fusion, we integrate multimodal MRIs and 
scans of histopathological images for indirect, fast, and cost saving IDH genotyping. 
5.2. Future Work 
This chapter introduces the work that we would like to implement into the procedure of 
multimodal medical image analysis; 
1. deep learning algorithms adopted for tumor segmentation and grading 
2. multi-task learning framework established for multi-parametric image features 
obtained from multimodal medical images 
3. correlation between histopathological images and molecular imaging. 
Deep learning: Accurate brain tumor segmentation is based on digital image 
processing. At present, the manual segmentation of clinical experts is still a recognized 
segmentation method, but this work is time-consuming and observe-dependent. Tumor 
incoherence and differences in contrast uptake will affect the segmentation of gliomas. 
It is inevitable to employe the machine-learning algorithm into glioma segmentation. 
For example, the combination of unsupervised classification with FCM and 
Knowledge-based image processing [56] can be applied on gliomas segmentation to 
segment non-enhancing tumors. Recently, deep learning has been implemented into 
automatic gliomas segmentation. For example, a 3D convolutional network [57] can be 
applied on the multimodal MRI glioma segmentation. However, for tumor 
segmentation and staging, the proposed methods need further study. 
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Multi-task learning: Competing with traditionally machine-learning 
algorithms, multi-task learning refers to a method that learns multiple related tasks 
together based on shared representations. As mentioned before, deep learning has been 
introduced into the field of medical image analysis, quantitative deep features have been 
dig out. In the future, we would like to combine the deep features and radiomics features 
we used in chapter 4 to implement into multi-task learning and achieve the better result 
in tumor segmentation or grading. 
Correlation between histopathological images and molecular imaging: On 
the account of vastly different image features of individual modalities, we would like 
to propose an information-theoretic approach to combine the multi-contribute features 
In the end, we hope to identify patterns or features extracted from MRIs that will help 
interpret the features from histopathological images. 
  
94 
 
Bibliography  
[1] X. Wang et al., "Machine learning models for multiparametric glioma grading 
with quantitative result interpretations," Frontiers in neuroscience, vol. 12, 
2018. 
[2] A. J. Méndez, P. G. Tahoces, M. a. J. Lado, M. Souto, and J. J. Vidal, 
"Computer‐aided diagnosis: Automatic detection of malignant masses in 
digitized mammograms," Medical Physics, vol. 25, no. 6, pp. 957-964, 1998. 
[3] G. D. Tourassi, "Journey toward computer-aided diagnosis: role of image 
texture analysis," Radiology, vol. 213, no. 2, pp. 317-320, 1999. 
[4] Q. Li and R. M. Nishikawa, Computer-aided detection and diagnosis in medical 
imaging. Taylor & Francis, 2015. 
[5]  S. P. Constantinos, M. S. Pattichis, and E. Micheli-Tzanakou, "Medical 
imaging fusion applications: An overview," in Conference Record of Thirty-
Fifth Asilomar Conference on Signals, Systems and Computers (Cat. No. 
01CH37256), 2001, vol. 2: IEEE, pp. 1263-1267.  
[6] K. Horsch, M. L. Giger, C. J. Vyborny, L. Lan, E. B. Mendelson, and R. E. 
Hendrick, "Classification of breast lesions with multimodality computer-aided 
diagnosis: observer study results on an independent clinical data set," Radiology, 
vol. 240, no. 2, pp. 357-368, 2006. 
[7] C. Demir and B. Yener, "Automated cancer diagnosis based on 
histopathological images: a systematic survey," Rensselaer Polytechnic 
Institute, Tech. Rep, 2005. 
95 
 
[8] J. Xu, X. Luo, G. Wang, H. Gilmore, and A. Madabhushi, "A deep 
convolutional neural network for segmenting and classifying epithelial and 
stromal regions in histopathological images," Neurocomputing, vol. 191, pp. 
214-223, 2016. 
[9] D. N. Louis et al., "The 2016 World Health Organization classification of 
tumors of the central nervous system: a summary," Acta neuropathologica, vol. 
131, no. 6, pp. 803-820, 2016. 
[10] N. Soomro and S. Bakhtiar, "Image-Based Modeling and Precision Medicine," 
in Progress and Challenges in Precision Medicine: Elsevier, 2017, pp. 141-170. 
[11] V. Bhateja, H. Patel, A. Krishn, A. Sahu, and A. Lay-Ekuakille, "Multimodal 
medical image sensor fusion framework using cascade of wavelet and 
contourlet transform domains," IEEE Sensors Journal, vol. 15, no. 12, pp. 6783-
6790, 2015. 
[12] C. He, Q. Liu, H. Li, and H. Wang, "Multimodal medical image fusion based 
on IHS and PCA," Procedia Engineering, vol. 7, pp. 280-285, 2010. 
[13] Y. Yang, Y. Que, S. Huang, and P. Lin, "Multimodal sensor medical image 
fusion based on type-2 fuzzy logic in NSCT domain," IEEE Sensors Journal, 
vol. 16, no. 10, pp. 3735-3745, 2016. 
[14] M. Manchanda and R. Sharma, "A novel method of multimodal medical image 
fusion using fuzzy transform," Journal of Visual Communication and Image 
Representation, vol. 40, pp. 197-217, 2016. 
[15] S. Das and M. K. Kundu, "NSCT-based multimodal medical image fusion using 
pulse-coupled neural network and modified spatial frequency," Medical & 
biological engineering & computing, vol. 50, no. 10, pp. 1105-1114, 2012. 
96 
 
[16] G. Qu, D. Zhang, and P. Yan, "Medical image fusion by wavelet transform 
modulus maxima," Optics Express, vol. 9, no. 4, pp. 184-190, 2001. 
[17]  R. Singh, M. Vatsa, and A. Noore, "Multimodal medical image fusion using 
redundant discrete wavelet transform," in 2009 Seventh International 
Conference on Advances in Pattern Recognition, 2009: IEEE, pp. 232-235.  
[18] B. Marshall, "A Brief History of the Discovery of Helicobacter pylori," in 
Helicobacter pylori: Springer, 2016, pp. 3-15. 
[19] J. C. Caicedo, F. A. González, and E. Romero, "Content-based histopathology 
image retrieval using a kernel-based semantic annotation framework," Journal 
of biomedical informatics, vol. 44, no. 4, pp. 519-528, 2011. 
[20]  N. Mehta, A. Raja'S, and V. Chaudhary, "Content based sub-image retrieval 
system for high resolution pathology images using salient interest points," in 
2009 Annual International Conference of the IEEE Engineering in Medicine 
and Biology Society, 2009: IEEE, pp. 3719-3722.  
[21] X. Qi et al., "Content-based histopathology image retrieval using CometCloud," 
BMC bioinformatics, vol. 15, no. 1, p. 287, 2014. 
[22] A. Sridhar, S. Doyle, and A. Madabhushi, "Content-based image retrieval of 
digitized histopathology in boosted spectrally embedded spaces," Journal of 
pathology informatics, vol. 6, 2015. 
[23]  J. A. Vanegas, J. Arevalo, and F. A. González, "Unsupervised feature learning 
for content-based histopathology image retrieval," in 2014 12th International 
Workshop on Content-Based Multimedia Indexing (CBMI), 2014: IEEE, pp. 1-
6.  
97 
 
[24] R. Sparks and A. Madabhushi, "Out-of-sample extrapolation utilizing semi-
supervised manifold learning (ose-ssl): Content based image retrieval for 
histopathology images," Scientific reports, vol. 6, p. 27306, 2016. 
[25] J. N. Weinstein et al., "The cancer genome atlas pan-cancer analysis project," 
Nature genetics, vol. 45, no. 10, p. 1113, 2013. 
[26] A. Yoshida et al., "Comprehensive histologic analysis of ALK-rearranged lung 
carcinomas," The American journal of surgical pathology, vol. 35, no. 8, pp. 
1226-1234, 2011. 
[27] M. Dal Molin et al., "Clinicopathological correlates of activating GNAS 
mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas," 
Annals of surgical oncology, vol. 20, no. 12, pp. 3802-3808, 2013. 
[28] H. Zhou et al., "MRI features predict survival and molecular markers in diffuse 
lower-grade gliomas," Neuro-oncology, vol. 19, no. 6, pp. 862-870, 2017. 
[29] F. G. Davis, S. Freels, J. Grutsch, S. Barlas, and S. Brem, "Survival rates in 
patients with primary malignant brain tumors stratified by patient age and tumor 
histological type: an analysis based on Surveillance, Epidemiology, and End 
Results (SEER) data, 1973–1991," Journal of neurosurgery, vol. 88, no. 1, pp. 
1-10, 1998. 
[30] A. D. Norden et al., "An exploratory survival analysis of anti-angiogenic 
therapy for recurrent malignant glioma," Journal of neuro-oncology, vol. 92, no. 
2, pp. 149-155, 2009. 
[31] B. Zhang et al., "Multimodal MRI features predict isocitrate dehydrogenase 
genotype in high-grade gliomas," Neuro-oncology, vol. 19, no. 1, pp. 109-117, 
2016. 
98 
 
[32] H. Yan et al., "IDH1 and IDH2 mutations in gliomas," New England Journal of 
Medicine, vol. 360, no. 8, pp. 765-773, 2009. 
[33] L. Lüdemann, W. Grieger, R. Wurm, M. Budzisch, B. Hamm, and C. Zimmer, 
"Comparison of dynamic contrast-enhanced MRI with WHO tumor grading for 
gliomas," European radiology, vol. 11, no. 7, pp. 1231-1241, 2001. 
[34] M. H. Lev et al., "Glial tumor grading and outcome prediction using dynamic 
spin-echo MR susceptibility mapping compared with conventional contrast-
enhanced MR: confounding effect of elevated rCBV of oligodendroglimoas," 
American Journal of Neuroradiology, vol. 25, no. 2, pp. 214-221, 2004. 
[35]  A. von Deimling, T. Ono, M. Shirahata, and D. N. Louis, "Grading of diffuse 
astrocytic gliomas: a review of studies before and after the advent of IDH 
testing," in Seminars in neurology, 2018, vol. 38, no. 01: Thieme Medical 
Publishers, pp. 019-023.  
[36] B. F. Waller, C. A. Pinkerton, and J. Slack, "Intravascular ultrasound: a 
histological study of vessels during life. The new'gold standard'for vascular 
imaging," Circulation, vol. 85, no. 6, pp. 2305-2310, 1992. 
[37] D. R. Genest, "Partial hydatidiform mole: clinicopathological features, 
differential diagnosis, ploidy and molecular studies, and gold standards for 
diagnosis," International journal of gynecological pathology, vol. 20, no. 4, pp. 
315-322, 2001. 
[38] L. B. Rorke, "Pathologic diagnosis as the gold standard," Cancer, vol. 79, no. 4, 
pp. 665-667, 1997. 
[39] S. Beer, "The viable system model: Its provenance, development, methodology 
and pathology," Journal of the operational research society, vol. 35, no. 1, pp. 
7-25, 1984. 
99 
 
[40] S. Park et al., "The history of pathology informatics: A global perspective," 
Journal of pathology informatics, vol. 4, 2013. 
[41] L. Pantanowitz et al., "Validating whole slide imaging for diagnostic purposes 
in pathology: guideline from the College of American Pathologists Pathology 
and Laboratory Quality Center," Archives of Pathology and Laboratory 
Medicine, vol. 137, no. 12, pp. 1710-1722, 2013. 
[42] M. D. Zarella et al., "A practical guide to whole slide imaging: a white paper 
from the digital pathology association," Archives of pathology & laboratory 
medicine, vol. 143, no. 2, pp. 222-234, 2018. 
[43] M. N. Gurcan, L. Boucheron, A. Can, A. Madabhushi, N. Rajpoot, and B. Yener, 
"Histopathological image analysis: A review," IEEE reviews in biomedical 
engineering, vol. 2, p. 147, 2009. 
[44] Y. Xu et al., "Large scale tissue histopathology image classification, 
segmentation, and visualization via deep convolutional activation features," 
BMC bioinformatics, vol. 18, no. 1, p. 281, 2017. 
[45] L. Landini, V. Positano, and M. Santarelli, Advanced image processing in 
magnetic resonance imaging. CRC press, 2018. 
[46] P. Korfiatis, T. L. Kline, and B. J. Erickson, "Automated segmentation of 
hyperintense regions in FLAIR MRI using deep learning," Tomography, vol. 2, 
no. 4, p. 334, 2016. 
[47]  L. Chato and S. Latifi, "Machine learning and deep learning techniques to 
predict overall survival of brain tumor patients using MRI images," in 2017 
IEEE 17th International Conference on Bioinformatics and Bioengineering 
(BIBE), 2017: IEEE, pp. 9-14.  
100 
 
[48] S. Napel, W. Mu, B. V. Jardim‐Perassi, H. J. Aerts, and R. J. Gillies, 
"Quantitative imaging of cancer in the postgenomic era: Radio (geno) mics, 
deep learning, and habitats," Cancer, vol. 124, no. 24, pp. 4633-4649, 2018. 
[49] D. L. Pham, C. Xu, and J. L. Prince, "Current methods in medical image 
segmentation," Annual review of biomedical engineering, vol. 2, no. 1, pp. 315-
337, 2000. 
[50] T. Heimann and H.-P. Meinzer, "Statistical shape models for 3D medical image 
segmentation: a review," Medical image analysis, vol. 13, no. 4, pp. 543-563, 
2009. 
[51] K. H. Zou et al., "Statistical validation of image segmentation quality based on 
a spatial overlap index1: scientific reports," Academic radiology, vol. 11, no. 2, 
pp. 178-189, 2004. 
[52] Y. Lin, J. Tian, and X.-p. Zhang, "Application of a new medical image 
segmentation method based on fuzzy connectedness and FCM," Chinese 
journal of stereology and image analysis, vol. 2, 2001. 
[53] M. M. Sharma, "Brain tumor segmentation techniques: A survey," Brain, vol. 
4, no. 4, pp. 220-223, 2016. 
[54] H. Jia, Y. Xia, Y. Song, W. Cai, M. Fulham, and D. D. Feng, "Atlas registration 
and ensemble deep convolutional neural network-based prostate segmentation 
using magnetic resonance imaging," Neurocomputing, vol. 275, pp. 1358-1369, 
2018. 
[55]  B. Gaonkar, D. Hovda, N. Martin, and L. Macyszyn, "Deep learning in the 
small sample size setting: cascaded feed forward neural networks for medical 
image segmentation," in Medical Imaging 2016: Computer-Aided Diagnosis, 
2016, vol. 9785: International Society for Optics and Photonics, p. 97852I.  
101 
 
[56] Y.-h. Liu, M. Muftah, T. Das, L. Bai, K. Robson, and D. Auer, "Classification 
of MR tumor images based on Gabor wavelet analysis," Journal of Medical and 
Biological Engineering, vol. 32, no. 1, pp. 22-28, 2012. 
[57]  S. Luo, R. Li, and S. Ourselin, "A new deformable model using dynamic 
gradient vector flow and adaptive balloon forces," in APRS Workshop on Digital 
Image Computing, Brisbane, Australia, 2003: Citeseer.  
[58] J. Sachdeva, V. Kumar, I. Gupta, N. Khandelwal, and C. K. Ahuja, "A novel 
content-based active contour model for brain tumor segmentation," Magnetic 
resonance imaging, vol. 30, no. 5, pp. 694-715, 2012. 
[59]  F. C. Ghesu, B. Georgescu, T. Mansi, D. Neumann, J. Hornegger, and D. 
Comaniciu, "An artificial agent for anatomical landmark detection in medical 
images," in International Conference on Medical Image Computing and 
Computer-Assisted Intervention, 2016: Springer, pp. 229-237.  
[60] T. M. Lehmann, C. Gonner, and K. Spitzer, "Survey: Interpolation methods in 
medical image processing," IEEE transactions on medical imaging, vol. 18, no. 
11, pp. 1049-1075, 1999. 
[61] R. C. Patil and A. Bhalchandra, "Brain tumour extraction from MRI images 
using MATLAB," International Journal of Electronics, Communication and 
Soft Computing Science & Engineering (IJECSCSE), vol. 2, no. 1, p. 1, 2012. 
[62] A. Chaddad, "Automated feature extraction in brain tumor by magnetic 
resonance imaging using gaussian mixture models," Journal of Biomedical 
Imaging, vol. 2015, p. 8, 2015. 
[63] A. Islam, S. M. Reza, and K. M. Iftekharuddin, "Multifractal texture estimation 
for detection and segmentation of brain tumors," IEEE transactions on 
biomedical engineering, vol. 60, no. 11, pp. 3204-3215, 2013. 
102 
 
[64] J. Luts et al., "Effect of feature extraction for brain tumor classification based 
on short echo time 1H MR spectra," Magnetic Resonance in Medicine: An 
Official Journal of the International Society for Magnetic Resonance in 
Medicine, vol. 60, no. 2, pp. 288-298, 2008. 
[65] A. Singh, M. K. Dutta, M. ParthaSarathi, V. Uher, and R. Burget, "Image 
processing based automatic diagnosis of glaucoma using wavelet features of 
segmented optic disc from fundus image," Computer methods and programs in 
biomedicine, vol. 124, pp. 108-120, 2016. 
[66] V. Rathi and S. Palani, "Brain tumor MRI image classification with feature 
selection and extraction using linear discriminant analysis," arXiv preprint 
arXiv:1208.2128, 2012. 
[67] T. Kurc et al., "Scalable analysis of Big pathology image data cohorts using 
efficient methods and high-performance computing strategies," BMC 
bioinformatics, vol. 16, no. 1, p. 399, 2015. 
[68]  A. Cruz-Roa et al., "Automatic detection of invasive ductal carcinoma in whole 
slide images with convolutional neural networks," in Medical Imaging 2014: 
Digital Pathology, 2014, vol. 9041: International Society for Optics and 
Photonics, p. 904103.  
[69] B. Q. Huynh, H. Li, and M. L. Giger, "Digital mammographic tumor 
classification using transfer learning from deep convolutional neural networks," 
Journal of Medical Imaging, vol. 3, no. 3, p. 034501, 2016. 
[70] N. Tajbakhsh et al., "Convolutional neural networks for medical image analysis: 
Full training or fine tuning?," IEEE transactions on medical imaging, vol. 35, 
no. 5, pp. 1299-1312, 2016. 
103 
 
[71]  W. M. Hafizah, E. Supriyanto, and J. Yunus, "Feature extraction of kidney 
ultrasound images based on intensity histogram and gray level co-occurrence 
matrix," in 2012 Sixth Asia Modelling Symposium, 2012: IEEE, pp. 115-120.  
[72] S. Kothari, J. H. Phan, T. H. Stokes, and M. D. Wang, "Pathology imaging 
informatics for quantitative analysis of whole-slide images," Journal of the 
American Medical Informatics Association, vol. 20, no. 6, pp. 1099-1108, 2013. 
[73] E. Mercan, S. Aksoy, L. G. Shapiro, D. L. Weaver, T. T. Brunyé, and J. G. 
Elmore, "Localization of diagnostically relevant regions of interest in whole 
slide images: A comparative study," Journal of digital imaging, vol. 29, no. 4, 
pp. 496-506, 2016. 
[74] T. Wan, J. Cao, J. Chen, and Z. Qin, "Automated grading of breast cancer 
histopathology using cascaded ensemble with combination of multi-level image 
features," Neurocomputing, vol. 229, pp. 34-44, 2017. 
[75] J. Saltz et al., "Spatial organization and molecular correlation of tumor-
infiltrating lymphocytes using deep learning on pathology images," Cell reports, 
vol. 23, no. 1, pp. 181-193. e7, 2018. 
[76] R. Albert, T. Schindewolf, I. Baumann, and H. Harms, "Three‐dimensional 
image processing for morphometric analysis of epithelium sections," Cytometry: 
The Journal of the International Society for Analytical Cytology, vol. 13, no. 7, 
pp. 759-765, 1992. 
[77] H. J. Aerts et al., "Decoding tumour phenotype by noninvasive imaging using a 
quantitative radiomics approach," Nature communications, vol. 5, p. 4006, 2014. 
[78] A. Zwanenburg, S. Leger, M. Vallières, and S. Löck, "Image biomarker 
standardisation initiative," arXiv preprint arXiv:1612.07003, 2016. 
104 
 
[79] J. J. Van Griethuysen et al., "Computational radiomics system to decode the 
radiographic phenotype," Cancer research, vol. 77, no. 21, pp. e104-e107, 2017. 
[80]  M. G. Ertosun and D. L. Rubin, "Automated grading of gliomas using deep 
learning in digital pathology images: A modular approach with ensemble of 
convolutional neural networks," in AMIA Annual Symposium Proceedings, 
2015, vol. 2015: American Medical Informatics Association, p. 1899.  
[81]  L. Hou, D. Samaras, T. M. Kurc, Y. Gao, J. E. Davis, and J. H. Saltz, "Patch-
based convolutional neural network for whole slide tissue image classification," 
in Proceedings of the IEEE Conference on Computer Vision and Pattern 
Recognition, 2016, pp. 2424-2433.  
[82] A. Kharrat, K. Gasmi, M. B. Messaoud, N. Benamrane, and M. Abid, "A hybrid 
approach for automatic classification of brain MRI using genetic algorithm and 
support vector machine," Leonardo journal of sciences, vol. 17, no. 1, pp. 71-
82, 2010. 
[83] C. Decaestecker et al., "Nearest-neighbor classification for identification of 
aggressive versus nonaggressive low-grade astrocytic tumors by means of 
image cytometry-generated variables," Journal of neurosurgery, vol. 86, no. 3, 
pp. 532-537, 1997. 
[84] J. Kazmierska and J. Malicki, "Application of the Naïve Bayesian Classifier to 
optimize treatment decisions," Radiotherapy and Oncology, vol. 86, no. 2, pp. 
211-216, 2008. 
[85] M. Artzi, G. Liberman, D. T. Blumenthal, O. Aizenstein, F. Bokstein, and D. 
Ben Bashat, "Differentiation between vasogenic edema and infiltrative tumor in 
patients with high‐grade gliomas using texture patch‐based analysis," Journal 
of Magnetic Resonance Imaging, vol. 48, no. 3, pp. 729-736, 2018. 
105 
 
[86]  D. Patel, F. Vankawala, and B. Bhatt, "A Survey on Identification of 
Glioblastoma Multiforme and Low-Grade Glioma Brain Tumor Type," in 2019 
International Conference on Communication and Signal Processing (ICCSP), 
2019: IEEE, pp. 0335-0339.  
[87] R. Shai et al., "Gene expression profiling identifies molecular subtypes of 
gliomas," Oncogene, vol. 22, no. 31, p. 4918, 2003. 
[88] R. Inano et al., "Voxel-based clustered imaging by multiparameter diffusion 
tensor images for glioma grading," NeuroImage: Clinical, vol. 5, pp. 396-407, 
2014. 
[89]  V. Kumar, J. Sachdeva, I. Gupta, N. Khandelwal, and C. K. Ahuja, 
"Classification of brain tumors using PCA-ANN," in 2011 World Congress on 
Information and Communication Technologies, 2011: IEEE, pp. 1079-1083.  
[90]  T. H. Vu, H. S. Mousavi, V. Monga, U. A. Rao, and G. Rao, "DFDL: 
Discriminative feature-oriented dictionary learning for histopathological image 
classification," in 2015 IEEE 12th International Symposium on Biomedical 
Imaging (ISBI), 2015: IEEE, pp. 990-994.  
[91] T. H. Vu, H. S. Mousavi, V. Monga, G. Rao, and U. A. Rao, "Histopathological 
image classification using discriminative feature-oriented dictionary learning," 
IEEE transactions on medical imaging, vol. 35, no. 3, pp. 738-751, 2015. 
[92] M. L. Goodenberger and R. B. Jenkins, "Genetics of adult glioma," Cancer 
genetics, vol. 205, no. 12, pp. 613-621, 2012. 
[93] D. N. Louis et al., "The 2007 WHO classification of tumours of the central 
nervous system," Acta neuropathologica, vol. 114, no. 2, pp. 97-109, 2007. 
[94] D. W. Hsu, D. N. Louis, J. T. Efird, and E. T. Hedley-Whyte, "Use of MIB-1 
(Ki-67) immunoreactivity in differentiating grade II and grade III gliomas," 
106 
 
Journal of Neuropathology & Experimental Neurology, vol. 56, no. 8, pp. 857-
865, 1997. 
[95] J. Cillekens et al., "A histopathological contribution to supratentorial glioma 
grading, definition of mixed gliomas and recognition of low grade glioma with 
Rosenthal fibers," Journal of neuro-oncology, vol. 46, no. 1, pp. 23-43, 2000. 
[96] R. Cavaliere, M. B. S. Lopes, and D. Schiff, "Low-grade gliomas: an update on 
pathology and therapy," The Lancet Neurology, vol. 4, no. 11, pp. 760-770, 
2005. 
[97] Y. Wang and T. Jiang, "Understanding high grade glioma: molecular 
mechanism, therapy and comprehensive management," Cancer letters, vol. 331, 
no. 2, pp. 139-146, 2013. 
[98] R. Rubin, D. S. Strayer, and E. Rubin, Rubin's pathology: clinicopathologic 
foundations of medicine. Lippincott Williams & Wilkins, 2008. 
[99] P. Burger, F. Vogel, and L. Rubinstein, "Surgical Pathology of the Nervous 
System and its Coverings," Journal of Neuropathology and Experimental 
Neurology, vol. 42, no. 3, 1983. 
[100] S. Bruno and Z. Darzynkiewicz, "Cell cycle dependent expression and stability 
of the nuclear protein detected by Ki‐67 antibody in HL‐60 cells," Cell 
proliferation, vol. 25, no. 1, pp. 31-40, 1992. 
[101] A. J. Skjulsvik, J. N. Mørk, M. O. Torp, and S. H. Torp, "Ki-67/MIB-1 
immunostaining in a cohort of human gliomas," International journal of clinical 
and experimental pathology, vol. 7, no. 12, p. 8905, 2014. 
[102] A. Madabhushi and G. Lee, "Image analysis and machine learning in digital 
pathology: Challenges and opportunities," ed: Elsevier, 2016. 
107 
 
[103] H. S. Mousavi, V. Monga, G. Rao, and A. U. Rao, "Automated discrimination 
of lower and higher grade gliomas based on histopathological image analysis," 
Journal of pathology informatics, vol. 6, 2015. 
[104] J. Kong, O. Sertel, H. Shimada, K. L. Boyer, J. H. Saltz, and M. N. Gurcan, 
"Computer-aided evaluation of neuroblastoma on whole-slide histology images: 
Classifying grade of neuroblastic differentiation," Pattern Recognition, vol. 42, 
no. 6, pp. 1080-1092, 2009. 
[105] O. Sertel, J. Kong, H. Shimada, U. Catalyurek, J. H. Saltz, and M. N. Gurcan, 
"Computer-aided prognosis of neuroblastoma on whole-slide images: 
Classification of stromal development," Pattern recognition, vol. 42, no. 6, pp. 
1093-1103, 2009. 
[106] J. Kong et al., "Machine-based morphologic analysis of glioblastoma using 
whole-slide pathology images uncovers clinically relevant molecular 
correlates," PloS one, vol. 8, no. 11, p. e81049, 2013. 
[107] P.-W. Huang and C.-H. Lee, "Automatic classification for pathological prostate 
images based on fractal analysis," IEEE transactions on medical imaging, vol. 
28, no. 7, pp. 1037-1050, 2009. 
[108]  S. M. Reza and K. M. Iftekharuddin, "Glioma grading using cell nuclei 
morphologic features in digital pathology images," in Medical Imaging 2016: 
Computer-Aided Diagnosis, 2016, vol. 9785: International Society for Optics 
and Photonics, p. 97852U.  
[109] P. Mobadersany et al., "Predicting cancer outcomes from histology and 
genomics using convolutional networks," Proceedings of the National Academy 
of Sciences, p. 201717139, 2018. 
108 
 
[110] Y. Al-Kofahi, W. Lassoued, W. Lee, and B. Roysam, "Improved automatic 
detection and segmentation of cell nuclei in histopathology images," IEEE 
Transactions on Biomedical Engineering, vol. 57, no. 4, pp. 841-852, 2010. 
[111] N. Kumar, R. Verma, S. Sharma, S. Bhargava, A. Vahadane, and A. Sethi, "A 
dataset and a technique for generalized nuclear segmentation for computational 
pathology," IEEE transactions on medical imaging, vol. 36, no. 7, pp. 1550-
1560, 2017. 
[112] R. Thawani et al., "Radiomics and Radiogenomics in Lung Cancer: A Review 
for the Clinician," Lung Cancer, 2017. 
[113] S. Selvarajah and S. Kodituwakku, "Analysis and comparison of texture 
features for content based image retrieval," International Journal of Latest 
Trends in Computing, vol. 2, no. 1, 2011. 
[114] Y. Saeys, I. Inza, and P. Larrañaga, "A review of feature selection techniques in 
bioinformatics," bioinformatics, vol. 23, no. 19, pp. 2507-2517, 2007. 
[115] A. Liaw and M. Wiener, "Classification and regression by randomForest," R 
news, vol. 2, no. 3, pp. 18-22, 2002. 
[116] J. H. Friedman, "Stochastic gradient boosting," Computational Statistics & 
Data Analysis, vol. 38, no. 4, pp. 367-378, 2002. 
[117] T. S. Furey, N. Cristianini, N. Duffy, D. W. Bednarski, M. Schummer, and D. 
Haussler, "Support vector machine classification and validation of cancer tissue 
samples using microarray expression data," Bioinformatics, vol. 16, no. 10, pp. 
906-914, 2000. 
[118] M. T. Hagan, H. B. Demuth, M. H. Beale, and O. De Jesús, Neural network 
design. Pws Pub. Boston, 1996. 
109 
 
[119] E. I. Zacharaki et al., "Classification of brain tumor type and grade using MRI 
texture and shape in a machine learning scheme," Magnetic Resonance in 
Medicine: An Official Journal of the International Society for Magnetic 
Resonance in Medicine, vol. 62, no. 6, pp. 1609-1618, 2009. 
[120]  J. Larsen and C. Goutte, "On optimal data split for generalization estimation 
and model selection," in Neural Networks for Signal Processing IX, 1999. 
Proceedings of the 1999 IEEE Signal Processing Society Workshop., 1999: 
IEEE, pp. 225-234.  
[121]  M. T. Ribeiro, S. Singh, and C. Guestrin, "Why should i trust you?: Explaining 
the predictions of any classifier," in Proceedings of the 22nd ACM SIGKDD 
international conference on knowledge discovery and data mining, 2016: ACM, 
pp. 1135-1144.  
[122] S. Kinjo, J. Hirato, and Y. Nakazato, "Low grade diffuse gliomas: shared 
cellular composition and morphometric differences," Neuropathology, vol. 28, 
no. 5, pp. 455-465, 2008. 
[123] M. H. Faria, B. Gonçalves, R. M. Patrocínio, M. O. d. Moraes‐Filho, and S. H. 
Rabenhorst, "Expression of Ki‐67, Topoisomerase IIα and c‐MYC in astrocytic 
tumors: Correlation with the histopathological grade and proliferative status," 
Neuropathology, vol. 26, no. 6, pp. 519-527, 2006. 
[124]  T. Shibata, P. Burger, and P. Kleihues, "Ki-67 immunoperoxidase stain as 
marker for the histological grading of nervous system tumours," in Proceedings 
of the 8th European Congress of Neurosurgery, Barcelona, September 6–11, 
1987, 1988: Springer, pp. 103-106.  
110 
 
[125] F. Kayaselçuk, S. Zorludemir, D. Gümürdülü, H. Zeren, and T. Erman, "PCNA 
and Ki-67 in central nervous system tumors: correlation with the histological 
type and grade," Journal of neuro-oncology, vol. 57, no. 2, pp. 115-121, 2002. 
[126] A. L. Johannessen and S. H. Torp, "The clinical value of Ki-67/MIB-1 labeling 
index in human astrocytomas," Pathology & Oncology Research, vol. 12, no. 3, 
p. 143, 2006. 
[127] S. Shuangshoti, Y. Navalitloha, V. Kasantikul, and A. Mutirangura, "Genetic 
heterogeneity and progression in different areas within high-grade diffuse 
astrocytoma," Oncology reports, vol. 7, no. 1, pp. 113-120, 2000. 
[128] C. Walker et al., "Characterisation of molecular alterations in microdissected 
archival gliomas," Acta neuropathologica, vol. 101, no. 4, pp. 321-333, 2001. 
[129] G. S. Stoyanov, D. L. Dzhenkov, M. Kitanova, I. S. Donev, and P. Ghenev, 
"Correlation Between Ki-67 Index, World Health Organization Grade and 
Patient Survival in Glial Tumors With Astrocytic Differentiation," Cureus, vol. 
9, no. 6, 2017. 
[130] M. B. S. Lopes, "The 2017 World Health Organization classification of tumors 
of the pituitary gland: a summary," Acta Neuropathologica, vol. 134, no. 4, pp. 
521-535, 2017. 
[131] J. Balss, J. Meyer, W. Mueller, A. Korshunov, C. Hartmann, and A. von 
Deimling, "Analysis of the IDH1 codon 132 mutation in brain tumors," Acta 
neuropathologica, vol. 116, no. 6, pp. 597-602, 2008. 
[132] L. He, L. R. Long, S. Antani, and G. R. Thoma, "Histology image analysis for 
carcinoma detection and grading," Computer methods and programs in 
biomedicine, vol. 107, no. 3, pp. 538-556, 2012. 
111 
 
[133] J. Torhorst et al., "Tissue microarrays for rapid linking of molecular changes to 
clinical endpoints," The American journal of pathology, vol. 159, no. 6, pp. 
2249-2256, 2001. 
[134] S. Robertson, H. Azizpour, K. Smith, and J. Hartman, "Digital image analysis 
in breast pathology—from image processing techniques to artificial 
intelligence," Translational Research, vol. 194, pp. 19-35, 2018. 
[135] K. E. Emblem et al., "A generic support vector machine model for preoperative 
glioma survival associations," Radiology, vol. 275, no. 1, pp. 228-234, 2014. 
[136] K. S. Choi, S. H. Choi, and B. Jeong, "Prediction of IDH genotype in gliomas 
with dynamic susceptibility contrast perfusion MR imaging using an 
explainable recurrent neural network," Neuro-oncology, 2019. 
[137] L. Macyszyn et al., "Imaging patterns predict patient survival and molecular 
subtype in glioblastoma via machine learning techniques," Neuro-oncology, vol. 
18, no. 3, pp. 417-425, 2015. 
[138] E. I. Zacharaki, N. Morita, P. Bhatt, D. O'rourke, E. Melhem, and C. Davatzikos, 
"Survival analysis of patients with high-grade gliomas based on data mining of 
imaging variables," American Journal of Neuroradiology, vol. 33, no. 6, pp. 
1065-1071, 2012. 
[139] B. M. Ellingson et al., "Volumetric analysis of functional diffusion maps is a 
predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in 
malignant gliomas," Journal of neuro-oncology, vol. 102, no. 1, pp. 95-103, 
2011. 
[140] P. Eichinger et al., "Diffusion tensor image features predict IDH genotype in 
newly diagnosed WHO grade II/III gliomas," Scientific reports, vol. 7, no. 1, p. 
13396, 2017. 
112 
 
[141] Z. Xing, X. Yang, D. She, Y. Lin, Y. Zhang, and D. Cao, "Noninvasive 
assessment of IDH mutational status in World Health Organization grade II and 
III astrocytomas using DWI and DSC-PWI combined with conventional MR 
imaging," American Journal of Neuroradiology, vol. 38, no. 6, pp. 1138-1144, 
2017. 
[142] Louis DN, Ohgaki H, Wiestler OD, and C. WK, World Health Organization 
Histological Classification of Tumours of the Central Nervous System. Lyon, 
France: International Agency for Research on Cancer (IARC), 2016. 
[143] M. Perizzolo, B. Winkfein, S. Hui, W. Krulicki, J. A. Chan, and D. J. Demetrick, 
"IDH Mutation Detection in Formalin‐Fixed Paraffin‐Embedded Gliomas 
Using Multiplex PCR and Single‐Base Extension," Brain Pathology, vol. 22, 
no. 5, pp. 619-624, 2012. 
[144] G. Reyes-Botero et al., "Molecular analysis of diffuse intrinsic brainstem 
gliomas in adults," Journal of neuro-oncology, vol. 116, no. 2, pp. 405-411, 
2014. 
[145] M. Sanson et al., "Isocitrate dehydrogenase 1 codon 132 mutation is an 
important prognostic biomarker in gliomas," J Clin Oncol, vol. 27, no. 25, pp. 
4150-4154, 2009. 
[146] Y. Al-Kofahi, W. Lassoued, W. Lee, and B. Roysam, "Improved automatic 
detection and segmentation of cell nuclei in histopathology images," IEEE 
Transactions on Biomedical Engineering, vol. 57, no. 4, pp. 841-852, 2009. 
[147] X. Wang et al., "Machine learning models for multiparametric glioma grading 
with quantitative result interpretations," Frontiers in neuroscience, vol. 12, p. 
1046, 2019. 
113 
 
[148] I. Guyon and A. Elisseeff, "An introduction to variable and feature selection," 
Journal of machine learning research, vol. 3, no. Mar, pp. 1157-1182, 2003. 
 
